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OVERVIEW 
This thesis aims to address some of the unresolved issues around emotion 
recognition in Huntington’s disease (HD).  HD is an autosomal dominant 
neurodegenerative disease, with symptoms usually occurring in the middle decades 
of life and death following approximately 20 years later.  Symptoms include 
involuntary movements (chorea), psychiatric disturbance (e.g. irritability, apathy), 
and cognitive difficulties, including difficulties recognising emotions. 
Part 1 of the thesis systematically reviews existing literature looking at emotion 
recognition in HD.  Since the late 90s this has been a topic of some interest, and in 
particular debate has centred around whether specific emotions are 
disproportionately affected, and the implications of this for the neural substrates of 
emotion recognition given the underlying neuropathology of the disease.  Therefore 
Part 1 aimed to assess systematically the findings to date, summarising outcomes and 
relevant methodological issues, and making recommendations for future research. 
Part 2 follows on from some of the recommendations made in Part 1.  Firstly, it 
examines emotion recognition in more than one modality in one HD cohort, and 
compares the results statistically (something which has not previously been 
reported).  Secondly it expands the domain of emotion recognition to include the 
more abstract concept of music emotion recognition, which has shown to be impaired 
in other neurodegenerative diseases and to rely on similar underlying brain regions. 
Finally Part 3 appraises the work presented in Parts 1 and 2, firstly by expanding on 
methodological limitations, and recommendations for future research, and secondly 
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by reflecting on the challenges of working with people suffering from a 
neurodegenerative disease. 
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ABSTRACT 
Aims 
There is increasing interest in the nature of the emotion recognition deficit in 
Huntington’s disease (HD) with conflicting reports of disproportionate impairments 
for some emotions in some modalities.  This review aimed to clarify the pattern of 
emotion recognition deficits in HD. 
Methods 
A systematic review and narrative synthesis was conducted for studies investigating 
emotion recognition in Huntington’s disease.  Embase, MEDLINE, PsychINFO and 
PubMed were searched from 1993 to 2010, and citation and reference list searches 
were also conducted.  1724 citations were identified. 
Results 
Sixteen studies met inclusion criteria.  In manifest HD recognition of facial anger 
was found most consistently, although recognition of all negative emotions (facial 
and vocal) tended to be impaired.  In premanifest HD impairments were inconsistent, 
but are seen in all facial expressions of negative emotion.  Inconsistency may 
represent the variability inherent in HD although may also be due to between-study 
differences in methodology. 
Conclusions 
Current evidence supports the conclusion that recognition of all negative emotions 
tends to be impaired in HD, particularly in the facial domain.  Future work should 
focus on using more ecologically-valid tests, and testing inter-modality differences.
1 INTRODUCTION 
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder 
caused by an expanded CAG repeat on chromosome 4.  It is classically characterised 
by involuntary movements and cognitive and psychiatric deficits, with the onset of 
motor signs usually occurring in mid-adulthood.  There is, however, often evidence 
for subtle cognitive and behavioural deficits ahead of these motor features (Lawrence 
et al., 1998; Snowden, Craufurd, Thompson, & Neary, 2002).  
The ability to recognise emotions in others is a key social skill, and much work has 
focused on studying the expression and recognition of canonical emotions 
(happiness, sadness, fear, surprise, anger and disgust) which appear to be cross-
cultural, and which it is argued have a biological basis (Ekman, 1992; Ekman, 1993).  
More recently, attempts have been made to elucidate the neural substrates of emotion 
recognition, with lesion studies and functional brain imaging providing new insights 
into the pathways underlying this skill (e.g., Calder, Keane, Lawrence, & Manes, 
2004; Phillips et al., 1998; Scott et al., 1997); for a review see Adolphs (2002). 
Over the last two decades there has been increasing interest in emotion recognition 
deficits in people with HD, and this interest is justified on both clinical and 
neurobiological grounds.  HD is relatively common (Harper, 2002; Novak & Tabrizi, 
2010) and has the potential for presymptomatic diagnosis (and therefore early 
intervention with disease-modifying therapies).  These factors lend particular 
urgency to the search for biomarkers of brain dysfunction in HD, and emotion 
recognition is a promising candidate (Paulsen et al., 2006; Stout et al., 2011; Tabrizi 
et al., 2009).  In addition, HD has contributed to the literature on models of emotion 
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recognition, as associations are made between the behavioural deficits seen in the 
disease, and the affected brain regions. 
An initial finding of disproportionately impaired recognition of facial expressions of 
disgust was found in people with early symptoms of the disease (Sprengelmeyer et 
al., 1996).  This was followed by suggestions that facial disgust recognition might 
also be affected in premanifest gene carriers (Gray, Young, Barker, Curtis, & 
Gibson, 1997), and that recognition of disgust in other modalities, such as voices, 
taste and odours (Hayes, Stevenson, & Coltheart, 2007; Mitchell, Heims, Neville, & 
Rickards, 2005), was also impaired.  However other work has failed to replicate the 
disproportionate impairment in disgust recognition, instead suggesting that 
recognition of all negative emotions is broadly affected in HD (Henley et al., 2008; 
Johnson et al., 2007; Milders, Crawford, Lamb, & Simpson, 2003).  The aim of this 
review was therefore to disambiguate the pattern of emotion recognition deficits in 
HD through a systematic appraisal of previous reports.   
This review is warranted to better understand the nature and progression of cognitive 
impairment in HD, and how it might impact on people with HD and their carers.  A 
better conceptualisation of the emotion recognition deficits in HD is important to 
improve understanding of the social interaction problems that occur in the disease.  
From this, more refined strategies for managing these problems might be developed.  
More fundamentally, the emotion processing deficit in HD and its brain mechanism 
may hold important clues to the pathophysiology of the disease.  In particular, a 
selective deficit of emotion comprehension would (if substantiated) potentially 
predict a relatively specific pathophysiological and anatomical substrate which could 
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in turn be targeted as a biomarker of disease modification in future therapeutic trials 
(Henley, Bates, & Tabrizi, 2005; Tabrizi et al., 2009). 
The purpose of this review was to appraise systematically the reported impairments 
in emotion recognition in HD.  It aims to assess the nature of the deficits reported, 
and to investigate whether differences in findings can be explained by disease-related 
factors, such as stage or CAG repeat length.  It asks what conclusions can be drawn 
from the current literature about which emotions people with HD struggle to 
recognise, and in which modalities, as well as trying to identify areas for future 
research. 
2 METHODS 
2.1 CRITERIA FOR CONSIDERING STUDIES FOR THIS REVIEW 
2.1.1 Types of studies 
In order to be eligible for inclusion in the review studies had to compare emotion 
recognition in a group of participants with Huntington’s disease with a control group 
(i.e. quasi-experimental design).  Emotion recognition was defined as any task in 
which stimuli conveying emotional information were presented, and for which 
participants were asked to state or choose which emotion they thought was 
represented by the stimuli.  The stimulus could be of any modality (e.g. visual, vocal) 
and of any form (e.g. static faces, videos).  Any target emotions were considered.  
Studies in which participants were asked to match emotions within a modality were 
excluded (e.g. selecting a happy face in response to a happy face stimulus); success 
on this task might be achieved using perceptual features alone.  Studies in which 
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participants were asked to match emotions across a modality (e.g. selecting an angry 
face in response to an angry voice) were included as this cannot be solved purely on 
the basis of the perceptual features of the stimuli.  
Studies looking exclusively at “mood” or emotion production, or semantic 
knowledge (e.g. about situations that might be expected to induce emotions) were 
excluded.  Editorials, reviews, commentaries, letters or other articles that contained 
no original data were excluded. 
2.1.2 Types of participants 
The patient group had to consist of participants carrying the gene coding for 
Huntington’s disease (Huntington's Disease Collaborative Research Group, 1993), 
confirmed by genetic analysis.  This excluded any studies done before genetic testing 
was available, but ensured that findings were specific to this population. 
Studies of both manifest and premanifest participants were included.  Manifest HD is 
conventionally defined as the point at which gene carriers develop hard motor signs.  
Clinically, this can be a useful way in which to define disease onset, although in 
practice more subtle motor, cognitive and behavioural deficits are usually present 
many years before this point (Huntington Study Group, 1996; Paulsen et al., 2008).  
The control group had to be neurologically normal participants.  Studies of any 
participants aged 18 or over were included.  Participants with onset prior to this age 
are likely to have very high CAG repeat lengths and a rapidly progressing disease 
process as well as immature emotion processing mechanisms, which may be 
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qualitatively dissimilar to those in adults (Gao & Maurer, 2010; Kremer, 2002, pp. 
43-44). 
2.1.3 Types of measures 
Studies must have reported a quantitative measure of emotion recognition. 
2.2 SEARCH METHODS FOR IDENTIFICATION OF STUDIES 
2.2.1 Electronic searches 
Searches were run in the following databases: Embase (1993 to July 2010), 
MEDLINE (1993 to July 2010), PsychINFO (1993 to July 2010) and PubMed (1993 
to July 2010). 
Searches were limited from 1993 to the present day, as studies carried out prior to 
this would necessarily have included participants without genetically-confirmed HD. 
The search used keywords “(Huntington* AND (emotion* OR cogniti* OR 
neuropsycho*)) NOT (mouse OR rat OR mice)”. Using Ovid the search was run on 
Embase, MEDLINE and PsychINFO simultaneously and results were then 
deduplicated (a function within Ovid). 
Only peer-reviewed published articles were accepted for inclusion in the review.  
Attempts were made to contact corresponding authors of all articles included in the 
review, either to ask for access to more demographic or experimental data, or to 
check queries about the study. 
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2.2.2 Searching other resources 
For each study included in the review, manual searches of reference lists were 
conducted and a citation search was also conducted to identify further potential 
studies. 
2.3 DATA COLLECTION AND ANALYSIS 
2.3.1 Selection of studies 
The initial searches identified 1724 citations (after de-duplication).  The title and 
abstract of each citation were examined independently by both the author and a 
colleague, Dr Marianne Novak, against the pre-specified inclusion and exclusion 
criteria listed above. 
104 citations could not be excluded on the basis of the title and abstract alone (a 
proportion of these did not have an abstract available).  The full text of these 
citations was obtained by the author to assess whether they fully met inclusion 
criteria.  One additional citation was identified from the reference list and citation 
search. 
2.3.2 Data extraction and management 
Data were extracted to a standardised data collection form.  This covered 
demographic information, details of emotion recognition tests, any background tests, 
results, and technical assessment. 
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2.3.3 Technical assessment  
Study structure and technical characteristics were assessed according to a number of 
criteria: sample size and power analysis; the nature of the control group; reporting of 
demographic data; the nature of stimuli, stimulus presentation and response options; 
ways in which potential confounding variables were measured and addressed; 
appropriate statistics; and reporting of quantitative outcome data.  Demographic data 
considered necessary in order to be able to compare groups adequately between 
studies were: age, gender, some measure of estimated IQ or educational level, and 
additionally in the gene-positive group, CAG repeat length, and some estimate of 
disease course e.g. disease duration, United Huntington’s Disease Rating Scale 
(UHDRS) motor score or an estimate of time to motor onset in premanifest subjects 
(e.g., Langbehn, Brinkman, Falush, Paulsen, & Hayden, 2004).  (Note that these 
demographic data were considered desirable in order to assess studies fully, but these 
were not criteria for inclusion in the review overall). 
2.3.4 Data synthesis 
Given that the data reviewed here were quantitative a meta-analytic approach was 
considered.  However ultimately a narrative synthesis was undertaken for two 
reasons.  Firstly, although attempts were made to contact representatives of all the 
studies included in the review, some authors were uncontactable and this meant that 
quantitative results were not available for all studies.  Secondly, the ways in which 
the HD cohorts varied between studies were not always clear (e.g. measures such as 
IQ, CAG repeat length, disease severity and duration were not always reported).  
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This meant that it would not be possible to determine the extent to which differences 
in effect size were attributable to these differences in the cohorts studied. 
3 RESULTS 
3.1 DESCRIPTION OF STUDIES 
3.1.1 Results of the search 
Sixteen reports met full inclusion criteria.  Appendix 1 summarises reasons for which 
89 studies that met initial inclusion criteria were excluded after the full text was 
examined.  Of the sixteen studies included, one or more individual experiments from 
five of them were subsequently excluded for not meeting criteria (see Appendix 2). 
3.1.2 Included studies 
See Table 3-1 for characteristics of included studies. 
3.1.2.1 Studies of facial emotion recognition 
The majority of studies (14/16) included at least one test of facial emotion 
recognition (exceptions were Hayes et al. (2007) and Mitchell et al. (2005)).  The 
two most commonly used face stimulus sets were 60 (or 24) static black and white 
images, from the Ekman and Friesen battery (Ekman & Friesen, 1976), 10 (or four) 
each for happiness, sadness, surprise, disgust, anger and fear, henceforth “Ekman 
Faces”; and the set of 30 face images1 morphing between these six canonical 
emotions from the FEEST (Young, Perrett, Calder, Sprengelmeyer, & Ekman, 2002).  
 
1 These images were based on the face known as “JJ” from the Ekman and Friesen set 
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In this latter test, the “Emotion hexagon”, presentation of the 30 face stimuli is 
repeated over six blocks, with results from the first block subsequently discarded as 
practice trials.  Three studies also included neutral face stimuli in at least one test 
(Johnson et al., 2007; Snowden et al., 2008; Tabrizi et al., 2009). 
Two studies used the same brief (24-stimulus) version of Ekman Faces (Gray et al., 
1997; Henley et al., 2008).  Some researchers opted to replace or supplement these 
tests with their own stimuli in a similar format (e.g., Aviezer et al., 2009; Snowden et 
al., 2008).  One study used colour video clips made by morphing between neutral and 
emotional still photographs (Montagne et al., 2006). 
One study also included a test of emotion recognition from eye regions only 
(Snowden et al., 2008). 
3.1.2.2 Studies of auditory emotion recognition 
Five studies included tests of emotion recognition in the auditory modality, testing 
either short non-verbal vocal sounds (e.g. laughter, growls) or prosody of spoken 
phrases constructed from non-words.  Three of these studies (Calder et al., 2010; 
Snowden et al., 2008; Sprengelmeyer, Schroeder, Young, & Epplen, 2006) used 
stimuli taken from the same set of non-verbal vocal sounds (Scott et al., 1997).  One 
study used their own non-verbal stimuli (Hayes et al., 2007), and two studies used 
the same “nonsense” word prosody recognition task (Sprengelmeyer et al., 1996; 
Sprengelmeyer et al., 2006). 
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3.1.2.3 Studies of emotion recognition in other modalities 
One study included a test of emotion recognition of static black and white pictures 
portraying body language (Aviezer et al., 2009) and one, looking specifically at 
disgust recognition, tested recognition of pleasant and disgusting tastes and odours 
(Mitchell et al., 2005). 
3.1.2.4 Response options 
All the studies, with the exception of Mitchell et al. (2005, investigating taste and 
odour perception) used a forced choice response paradigm, in which participants 
were given a limited set of written verbal emotion terms and asked to pick the one 
that best described the stimulus. 
3.1.2.5 Study populations 
Eight studies included a sample of premanifest HD gene carriers, and 10 included a 
sample of people with manifest HD (i.e. unequivocal motor signs).  One study 
included both premanifest and manifest participants in the patient group (Aviezer et 
al., 2009). 
Study populations were drawn from a range of countries, including the United 
Kingdom (7), Australia (4), Germany (3), Canada (3), The Netherlands (2), France 
(1) and the United States (1).  Ethnicities of participants in each country were not 
reported in any study.  Culturally, this is a relatively restricted sample, based almost 
entirely on Western / European (the majority English-speaking) countries. 
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Table 3-1 Characteristics of included studies 
Study Demographic data Stimuli & response options 
 Control HD (premanifest & 
mild) 
N 27 21 
Age 49.2 (10) 48.3 (10.1) 
Gender (% F) 56% 57% 
CAG  42.85 (3.69) 
Estimated IQ - - 
UHDRS Motor  8.26 (8.02) 
 
 
Aviezer et al. 
(2009) Expt. 1a 
Country Canada 
 
 
1) 6 b&w pictures of body language, shown 3 times on computer; 6AFC, no time 
limit 
2) 40 Ekman faces, shown once on computer; 6AFC, no time limit 
    
  Control Manifest HD 
N Varies from 20 to 52 21 (20 for morphs) 
Age “Matched” 50.43 (8.7) 
Gender (% F) Varies 43% 
CAG  Genetically confirmed 
in most participants 
Estimated IQ “Matched” 107.38 (8.40) 
UHDRS Motor  30.45 (13.10) 
Calder et al. 
(2010) Study 1b 
Country United Kingdom 
 
1) 60 Ekman faces, shown on computer for up to 3 sec; 6AFC, no time limit 
 
2) 30 b&w morphs “Emotion Hexagon”; 5 blocks of 30 (plus practice block), each 
morph shown on computer for 5 sec; 6AFC, no time limit 
 
3) 60 non-verbal vocal sounds; 6AFC, no time limit 
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Study Demographic data Stimuli & response options 
  Control Premanifest HD 
N 23 17 (2 early manifest) 
Age 38.26 (11.82) 38.53 (11.24) 
Gender (% F) - - 
CAG  - 
Estimated IQ - - 
UHDRS Motor  - 
Gray et al. (1997) 
Country United Kingdom 
 
1) 24 Ekman faces, shown on card after 6 practice items; 6AFC, no time limit 
     
  Control Manifest HD 
N 14 14 
Age 51.3 (9.25) 54.6 (11.16) 
Gender (% F) 43% 43% 
CAG  - 
Years in education 11.8 (2.04) 11.8 (2.12) 
Disease duration  6.7 (5.21) 
Hayes et al. 
(2007) 
Country Australia 
 
1) 40 non-verbal vocal sounds; 4AFC, no time limit 
     
  Control Manifest HD 
N 14 14 
Age 51.8 (8.37) 54.6 (11.17) 
Gender (% F) 50% 43% 
CAG  - 
Years in education 11.8 (1.81) 11.8 (2.12) 
Disease duration  6.7 (5.21) 
Hayes et al. 
(2009) 
Country Australia 
 
1) Emotion Hexagon (see Calder et al. entry, above) 
 
2) 35 b&w morphs based on Ekman faces, at different intensities ranging from 0 to 
150%, 5 blocks of 35 (plus 5 practice stimuli), each morph shown on computer; 
6AFC 
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Study Demographic data Stimuli & response options 
  Control Premanifest Manifest 
N 20 21 40 
Age 44.9 (10.5) 37.2 (7.9) 48.5 (9.6) 
Gender (% F) 65% 52% 50% 
CAG  42.2 (1.8) 43.7 (2.4) 
Estimated IQ 106.2 (11.6) 103.2 (9.3) 105.3 (13.0) 
UHDRS Motor 1.1 (0.9) 3.6 (4.0) 28.9 (12.6) 
 
1) 24 Ekman faces, shown on card after 6 practice items; 6AFC, no time limit Henley et al. 
(2008) 
Country United Kingdom  
    
 Control Premanifest HD 
N 9 9 
Age “Matched” 37.4 (5.4) 
Gender (% F) 44% 44% 
CAG  43.7 (1.7) 
Estimated IQ “Matched” 112.9 (11.1) 
UHDRS Motor   
 
Hennenlotter et 
al. (2004) 
Country Germany 
 
1) Emotion Hexagon (see above) 
    
  Control Premanifest HD 
N 57 464 
Age, yr 43.01 (10.13) 41.43 (9.63) 
Gender (%F) 61% 63% 
CAG <30 >39 
Years in education 15.11 (2.29) 14.48 (2.59) 
UHDRS Motor   
Johnson et al. 
(2007) 
Country United States, Canada, Australia 
 
1) 70 Ekman faces, shown on computer touch screen for up to 4 sec after 7 practice 
trials using verbal labels instead of faces; 7AFC, up to 8 sec to respond using touch 
screen 
    
  
27 
Study Demographic data Stimuli & response options 
  Control Premanifest HD 
N 13 17 
Age, yr 42.0 (11.4) 43.8 (10.0) 
Gender (%F) 31% 47% 
CAG 20 (3.3) 41 (2.8) 
Estimated IQ - - 
UHDRS Motor 3.6 (1.8) 6.4 (3.9) 
Kipps et al. 
(2007) 
Country Australia 
 
1) Emotion Hexagon (see above) 
      
  Control Premanifest Manifest 
N 20 20 20 
Age, yr 47.9 (9.3) 38.4 (9.5) 47.6 (8.45) 
Gender (%F) 40% 65% 40% 
CAG  - - 
Estimated IQ 109.0 (6.0) 110.1 (6.1) 105.8 (7.41) 
Disease duration   6.5 (3.2) 
Milders et al. 
(2003) 
Country United Kingdom 
 
1) 60 Ekman faces, shown on card; 6AFC, no time limit 
    
  Control Manifest HD 
N 8 (6 for odours) 8 (6 for odours) 
Age, yr 49.25 (4.86) 53.25 (7.25) 
Gender (%F) 50% 50% 
CAG  - 
Estimated IQ - - 
UHDRS Motor  - 
Mitchell et al. 
(2005)c 
Country United Kingdom 
 
1) 5 disgusting & 5 pleasant odours, presented once for up to 5 sec; rate odour on 
10cm anchored line scale from very pleasant to very disgusting 
 
2) 6 everyday foods, presented individually and then in 4 appropriate & 4 
inappropriate pairings; rate taste as for expt. 1 above 
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Study Demographic data Stimuli & response options 
  Control Manifest HD 
N 30 7 
Age, yr 39.0 (11.1) 46.4 (11.2) 
Gender (%F) 53% 29% 
CAG  - 
Estimated IQ - - 
UHDRS Motor  17.1 (6.2) 
Montagne et al. 
(2006) 
Country The Netherlands 
 
1) 54 colour videos (9 different intensities for each of 6 emotions), made by 
morphing stills from actors, presented in 9 blocks of increasing intensity (20% - 
100%); 6AFC, no time limit 
    
  Control Manifest HD 
N 12 10 
Age, yr 57 (9) 47 (9) 
Gender (%F) 33% 50% 
CAG  - 
Estimated IQ 108.0 (6.7) 103.6 (10.7) 
Disease duration  7 (3) 
Snowden et al. 
(2008)d 
Country United Kingdom 
 
1) 60 Ekman faces; 6AFC, no time limit 
 
2) 60 Ekman faces; 2AFC, no time limit 
 
3) 120 non-verbal vocal sounds (20 for each of 6 emotions); 6AFC, no time limit 
 
4) 35 b&w faces, “Manchester” set (5 for each of 7 emotions plus 5 practice 
items); 7AFC, no time limit 
 
5) 35 b&w eye regions, “Manchester” set (as (4)); 7AFC, no time limit 
    
  Control Manifest HD 
N 17 13 (11 for study 2) 
Age, yr 50.7 (14.3) 45.0 (7.6) 
Gender (%F) 47% 54% 
CAG  45.2 (4.9) (N=11) 
Estimated IQ 107.5 (10.0) 105.6 (10.7) 
Disease duration  6.6 (2.5) 
Sprengelmeyer et 
al. (1996) 
Country Germany 
 
1) Emotion Hexagon (see above) 
 
2) 60 Ekman faces, shown on computer for up to 3 sec; 6AFC, no time limit 
 
3) 60 “nonsense” sentences spoken with emotional prosody; 6AFC, no time limit 
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Study Demographic data Stimuli & response options 
  Control Premanifest HD 
N 8 (6)e 14 (12)e 
Age, yr 38.3 (14.5) 31.0 (8.5) 
Gender (F:M) 75% 64% 
CAG 20.4 (3.8) 45.1 (4.0) 
Estimated IQ 108.8 (9.7) 113.2 (8.1) 
UHDRS Motor   
Sprengelmeyer et 
al. (2006) 
Country Germany 
 
1) 60 Ekman faces, shown on computer for up to 3 sec; 6AFC, no time limit 
 
2) Emotion Hexagon (see above) 
 
3) 60 “nonsense” sentences spoken with emotional prosody; 6AFC, no time limit 
 
4) 60 non-verbal vocal sounds; 6AFC, no time limit 
    
  Control Premanifest Manifest 
N 123 120 123 
Age, yr 46.1 (10.2) 40.8 (8.9) 48.8 (9.9) 
Gender (%F) 55% 55% 54% 
CAG  43.1 (2.4) 43.7 (3.0) 
Years in 
educationg 
4.0 (1.3) 3.9 (1.2) 3.6 (1.3) 
UHDRS Motor   23.7 (10.8) 
Tabrizi et al. 
(2009)f 
Country Canada, France, The Netherlands, United 
Kingdom 
 
1) 70 Ekman faces, shown on computer touch screen for up to 4 sec after 7 practice 
trials using verbal labels instead of faces; 7AFC, up to 8 sec to respond using touch 
screen 
Note: “Ekman faces” are always black & white (see text) 
A hyphen denotes data not reported; an empty cell denotes variable not applicable 
AFC = Alternative Forced Choice 
Attempts were made to contact representatives of all studies included in the review to resolve queries; responses were received from most authors other than Drs Hayes, 
Hennenlotter and Sprengelmeyer 
a CAG and UHDRS motor data provided by Dr Hillel Aviezer (personal communication) 
b Discrepant age data and CAG confirmation provided by Prof Andy Calder (personal communication) 
c Age and gender data provided by Dr Ian Mitchell (personal communication) 
d IQ data provided by Dr Julie Snowden and Dr Jennifer Thompson (personal communication) 
e Figures in brackets denote N at timepoints 2 and 3; data are given for all subjects at timepoint 1 
f CAG repeat length and UHDRS motor score provided by Prof Sarah Tabrizi and the Track-HD team (personal communication) 
g UNESCO International Standard Classification of Education: Level 3 qualifications typically start at the end of compulsory education (after 11 years of schooling in the UK) 
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3.2 ASSESSMENT OF METHODOLOGICAL FACTORS 
Study methodology was assessed in four distinct categories: choice of control group; 
reporting of key demographic data and results; stimulus type, presentation and 
response options; and reporting of statistical analysis, including discussion of power, 
potential confounds and the issue of multiple comparisons (Table 3-2). 
3.2.1 Reporting of key demographic data and results 
Huntington’s disease is highly heterogeneous, and clinical presentation is known to 
depend on age and CAG repeat length (and their interaction), which explain some of 
the variance in age of motor onset (see e.g., Mahant, McCusker, Byth, & Graham, 
2003; Rosenblatt et al., 2006).  It is therefore important to be able to rule out 
differences in the clinical characteristics of cohorts as a potential cause of differences 
between study findings.  In addition, factors such as age, education and intelligence, 
and possibly gender, may affect performance on cognitive tasks in both HD and 
control groups.  The impact of these factors both within studies (between patient and 
control groups) and between studies needs to be taken into account when assessing 
differences in outcome.  Consequently it is important for studies to report summary 
data for each of these variables, so that the effects (if any) of these potential 
confounds can be judged. 
Four studies were considered to have reported adequate demographic data: age, 
gender, an index of intellectual ability, CAG repeat length, and an index of disease 
severity (Henley et al., 2008; Hennenlotter et al., 2004; Sprengelmeyer et al., 1996; 
Sprengelmeyer et al., 2006).  Most others reported most of the above variables but 
many did not have CAG repeat data available; in these cases although participants 
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had undergone genetic testing for confirmation of diagnosis, researchers had not 
always requested (or been granted access to) the exact CAG data.  Some lacked an 
estimate of intelligence or educational level, although some authors were able to 
provide the extra data on request. 
Also of note is the fact that studies varied in their definition of pathological CAG 
repeat length.  Typically alleles of up to 35 repeats are considered normal, whilst 
alleles with 40 or more repeats are fully penetrant and the carrier is likely to show 
signs of HD within a normal lifespan.  The intermediate repeat numbers (36-39) are 
not fully penetrant but there have been reports of 36 CAG repeats leading to the 
disease, and of people living into their 90s with 39 CAG repeats and no signs of HD 
(Rubinsztein et al., 1996).  Whilst the majority of studies tend to include participants 
with a CAG repeat length of 40 or above, at least two included participants with 
CAG repeat lengths between 36 and 39 (Aviezer et al., 2009; Tabrizi et al., 2009), 
and not all report their criteria.  This raises the possibility that some participants may 
not be representative of the more general HD population. 
The majority of studies reported their findings in full (i.e. gave quantitative measures 
of central tendency and spread in each of the groups tested).  A number of authors 
made their raw data available on request if they were not available in the published 
paper.  Some authors preferred to report composite scores (Sprengelmeyer et al., 
2006; Tabrizi et al., 2009), and were able to justify this, although this makes it 
difficult to draw direct comparisons between individual tests. 
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3.2.2 Choice of control group 
Control groups were of three different kinds.  Ten studies used healthy volunteers as 
controls; five used gene-negative controls from an HD environment (either people 
who had been at risk and tested negative for the HD gene, or partners of gene-
positive participants); and one study used at-risk gene-negative controls who were 
unaware of their negative gene status when they completed the study tests. 
3.2.3 Stimulus type, presentation and response options 
As mentioned above, the majority of studies used very similar stimulus sets.  Facial 
stimuli were usually based on the Ekman and Friesen set (Ekman & Friesen, 1976).  
However there are a number of variations of this: whether simple faces or the 
Emotion Hexagon are used, whether or not neutral faces are included, and the overall 
number of stimuli used.  Only two studies included non-Ekman facial stimuli, one 
using a similar black and white static set (Snowden et al., 2008) and one making their 
own colour videos from actors (Montagne et al., 2006). 
Similarly, studies of vocal emotion recognition tended to use stimuli drawn from the 
same set (either the non-verbal vocal sounds, see Calder et al., 2004; Scott et al., 
1997; or the prosodic stimuli used by Sprengelmeyer et al., 1996).  One exception 
was Hayes et al. (2007) where it seems that novel non-verbal vocal stimuli were 
used. 
There were a number of subtle variations of presentation and response options, 
particularly pertinent to facial stimuli as these are not naturally time-limited (as for 
example are auditory stimuli).  Some faces were presented for a limited time, others 
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were presented until participants had made a choice.  As mentioned above, in the 
Emotion Hexagon test each stimulus is repeated six times (responses from the first 
presentation being discarded as practice items), whereas in simple face tests each 
stimulus is presented only once. 
Most studies did not impose a fixed time to respond, but two limited the time 
available in which a response could be made (Johnson et al., 2007; Tabrizi et al., 
2009).  All studies of facial and vocal emotion recognition used an alternative forced 
choice (AFC) response paradigm, but they varied in the choices given.  Most gave 
the same number of response options as there were emotion categories (e.g. if six 
different emotions were presented, there would be six response options).  One 
deliberately reduced the number of responses (Snowden et al., 2008) in order to 
evaluate performance when task demands were decreased.  One study used a 6AFC 
response when only four different emotions were represented in the stimuli (Aviezer 
et al., 2009). 
3.2.4 Statistical analysis 
3.2.4.1 Power analysis and sample size 
Only two studies reported considerations of power and sample size calculation 
(Johnson et al., 2007; Tabrizi et al., 2009).  These were the two largest studies (over 
100 participants in the patient groups), and both had calculated that they were 
adequately powered to detect relatively small effects in premanifest and manifest HD 
populations.  Sample sizes in the remaining studies ranged from six participants with 
manifest HD (Mitchell et al., 2005, odour test) to 40 (Henley et al., 2008). 
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3.2.4.2 Potential confounds 
Potential confounds were dealt with in a number of different ways.  Almost all 
studies reported gender, age and some measure of estimated pre-morbid intelligence 
or educational level.  Most of these reported that groups were “matched” for one or 
more of these variables, and some, but not all, reported a statistic to confirm that 
there were no statistically significant differences between groups.  Four studies 
included some or all of these variables as covariates in their analysis (Henley et al., 
2008; Johnson et al., 2007; Milders et al., 2003; Tabrizi et al., 2009). 
Almost all studies that tested facial emotion recognition included a standard test of 
face recognition1, and sometimes a test of visual acuity or contrast sensitivity, and 
other visual or face processing tasks (the exception was Tabrizi et al. (2009), which 
was designed to assess potential biomarkers, rather than to test facial emotion 
recognition per se).  One study excluded two participants with poor acuity (Aviezer 
et al., 2009), and no other studies reported impairments in basic visual skills.  Six 
studies reported that performance on the Benton Facial Recognition Test was 
significantly worse in HD groups than control groups.  Two took this into account in 
their analysis: one adjusted for facial recognition ability by including Benton score as 
a covariate in the analysis (Henley et al., 2008) and one investigated whether Benton 
scores correlated with emotion recognition scores (Snowden et al., 2008).  The others 
did not take poor Benton performance into account in the emotion recognition 
analysis although mean (SD) data in most cases suggest that some participants may 
 
1 Benton Facial Recognition Test (Benton, Sivan, Hamsher, Varney, & Spreen, 1978) 
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have fallen into the “moderately impaired” range.  In two studies in which a group 
difference was not found on the Benton, some HD participants still scored in the 
“moderate impairment” or “severe impairment” range although this is not 
commented on (Aviezer et al., 2009; Gray et al., 1997).  In addition to those studies 
that reported group differences in Benton score, one study included Benton as a 
covariate in the main analyses although did not report whether group differences 
were statistically significant (Johnson et al., 2007). 
Studies that included auditory stimuli did not report testing auditory perception.  The 
one study that investigated taste and olfactory recognition tested olfactory 
identification and threshold and excluded two HD participants from the olfactory 
experiment on the basis of poor performance (Mitchell et al., 2005). 
3.2.4.3 Normality of data 
The majority of studies noted that data did not meet assumptions needed for 
parametric statistics.  Many cited ceiling effects and used non-parametric tests (e.g. 
techniques such as Mann-Whitney tests, or bootstrap confidence intervals), whilst 
some just acknowledged heterogeneity of residual variance between groups and used 
appropriate statistics for this. 
Five studies used parametric statistics and did not discuss whether the data were 
normally distributed (Aviezer et al., 2009; Hayes et al., 2007; Milders et al., 2003; 
Mitchell et al., 2005; Montagne et al., 2006).  One study used non-parametric 
statistics for behavioural data, but opted to use parametric statistics on untransformed 
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mean reaction time data, although it would seem likely that such data might have 
been positively skewed (Sprengelmeyer et al., 2006). 
3.2.4.4 Multiple statistical comparisons 
All studies reported several statistical comparisons.  Three studies reported 
Bonferroni-corrected results (controlling the false positive rate across a number of 
comparisons) (Calder et al., 2010; Hayes et al., 2007; Milders et al., 2003).  Three 
studies discussed the increased risk of false positives but preferred to maximise 
power by reporting uncorrected results (Henley et al., 2008; Snowden et al., 2008; 
Sprengelmeyer et al., 2006).  The remaining ten studies did not discuss this issue. 
3.2.4.5 Reporting of analysis and results 
The majority of studies reported their analysis and test results clearly.  Most studies 
reported two-tailed tests.  Four studies chose to use one-tailed tests for some or all of 
their comparisons based on a priori predictions that the HD group would, on 
average, do worse than controls (Gray et al., 1997; Hennenlotter et al., 2004; Kipps, 
Duggins, McCusker, & Calder, 2007; Sprengelmeyer et al., 2006) although despite 
this, Sprengelmeyer et al. (2006) report one test in which the HD group outperformed 
the control group. 
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Table 3-2 Technical assessment 
Study 
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Aviezer et al. 2009 ■ ■ ■ ■ ■ 
Calder et al. 2010 ■ ■ ■ ■ ■ 
Gray et al. 1997 ■ ■ ■ ■ ■ 
Hayes et al. 2007 ■ ■ ■ ■ ■ 
Hayes et al. 2009 ■ ■ ■ ■ ■ 
Henley et al. 2008 ■ ■ ■ ■ ■ 
Hennenlotter et al. 2004 ■ ■ ■ ■ ■ 
Johnson et al. 2007 ■ ■ ■ ■ ■ 
Kipps et al. 2007 ■ ■ ■ ■ ■ 
Milders et al. 2003 ■ ■ ■ ■ ■ 
Mitchell et al. 2005 ■ ■ ■ ■ ■ 
Montagne et al. 2006 ■ ■ ■ ■ ■ 
Snowden et al. 2008 ■ ■ ■ ■ ■ 
Sprengelmeyer et al. 1996 ■ ■ ■ ■ ■ 
Sprengelmeyer et al. 2006 ■ ■ ■ ■ ■ 
Tabrizi et al. 2009 ■ ■ ■ ■ ■ 
Control type: ■ = gene-negative / spouses; ■ = gene-negative unaware of status; ■ = healthy 
volunteers 
Power analysis / sample size: ■ = analysis performed; ■ = no analysis performed 
Normality of data considered: ■ = discussed, and stats adapted accordingly; ■ = stats adjusted for 
inhomogeneity of variance only; ■ = not discussed 
Multiple comparisons addressed: ■ = discussed and addressed; ■ = not discussed 
Confounds measures and controlled for: ■ = effect of potentially confounding variables taken into 
account in analysis; ■ = effect of some potentially confounding variables taken into account in 
analysis; ■ = not considered 
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3.3 OUTCOMES 
Outcomes are described separately for manifest and premanifest populations as this 
is how the majority of studies were designed.  As discussed above, this is a 
somewhat arbitrary distinction, based on an assessment of motor symptoms.  There is 
inevitably variation between clinicians with regard to when symptoms are sufficient 
to make a diagnosis of manifest disease, and different studies use different cut-off 
points to define this.  Aviezer et al. (2009) included both manifest and premanifest 
participants in a single group in their study.  Examination of their data shows that 
nine out of 21 participants who completed the study had a UHDRS motor score of 
five or less, a cut-off used elsewhere to discriminate between manifest and 
premanifest participants (Tabrizi et al., 2009).  Therefore since the majority of 
participants had clear signs of the disease, Aviezer et al.’s results are reported below 
as representing manifest HD. 
3.3.1 Facial emotion recognition 
In participants with manifest HD the most consistent impairment was shown for 
recognition of facial anger: this was found to be impaired in every study that 
included a test for it.  Disgust recognition was also found to be impaired in almost 
every study that tested it, with the exception of Snowden et al. (2008) in a task in 
which they gave a two-alternative forced choice response option to the Ekman faces, 
instead of the usual six (i.e. they reduced task demands); anger and fear recognition 
were still impaired in this condition.  Fear recognition was often found to be 
impaired, although only using Ekman stimuli (not moving facial stimuli (Montagne 
et al., 2006), or a non-Ekman stimulus set, the "Manchester" set, a different, locally-
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made set of black-and-white static emotion faces (see Snowden et al., 2008).  
Sadness and surprise recognition were found to be impaired less often, whilst an 
impairment in happiness recognition was only found by two groups (Calder et al., 
2010; Hayes, Stevenson, & Coltheart, 2009) (Table 3-3
Table 3-3
). 
In premanifest participants an impairment in disgust recognition was most frequently 
reported and was seen in five out of eight studies.  Three of these reported that 
disgust was selectively impaired (Gray et al., 1997; Hennenlotter et al., 2004; 
Sprengelmeyer et al., 2006), whilst two found an impairment across negative 
emotions (Johnson et al., 2007; Tabrizi et al., 2009).  Sprengelmeyer et al. (2006) 
also reported a deficit in surprise recognition at the third of three timepoints tested.  
The remaining three studies found no evidence of impairment at all in premanifest 
participants, although one study explained a finding of impaired happiness 
recognition as an artefact of the ceiling effect in controls for that emotion (Henley et 
al., 2008).  
Snowden et al. (2008) found that manifest HD participants were impaired at 
recognising sadness and disgust from the eye regions alone ( ). 
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Table 3-3 Facial emotion recognition results 
Population Study Stimuli Ha Sa Su Di An Fe Ne 
Aviezer et al. 2009 Ekman faces ○ ○  ● ●   
Calder et al. 2010 Ekman faces ● ● ● ● ● ●  
 Emotion hexagon ● ● ● ● ● ●  
Hayes et al. 2009 Emotion hexagon ○ ● ● ● ● ●  
 Ekman faces at different intensities ○ ●  ● ● ●  
Henley et al. 2008 Ekman faces ○ ○ ● ● ● ●  
Milders et al. 2003 Ekman faces ○ ● ○ ● ● ●  
Montagne et al. 2006 Videos at different intensities ○ ○ ○ ● ● ○  
Snowden et al. 2008 Ekman faces (6AFC) ○ ● ● ● ● ●  
 Ekman faces (2AFC) ○ ○ ○ ○ ● ●  
 Manchester faces ○ ○ ○ ● ● ○ ○ 
Sprengelmeyer et al. 1996 Emotion hexagon ○ ● ● ● ● ●  
 Ekman faces ○ ● ● ● ● ●  
Manifest HD 
Tabrizi et al. 2009a Ekman faces (○) (●) (○) (●) (●) (●) (○) 
          
Manifest HD Snowden et al. 2008 Manchester eyes ○ ● ○ ● ○ ○ ○ 
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Population Study Stimuli Ha Sa Su Di An Fe Ne 
Gray et al. 1997 Ekman faces ○ ○ ○ ● ○ ○  
Henley et al. 2008 Ekman faces ● ○ ○ ○ ○ ○  
Hennenlotter et al. 2004 Emotion hexagon ○ ○ ○ ● ○ ○  
Johnson et al. 2007 Ekman faces ○ ● ○ ● ● ● ○ 
Kipps et al. 2007 Emotion hexagon ○ ○ ○ ○ ○ ○  
Milders et al. 2003 Ekman faces ○ ○ ○ ○ ○ ○  
Sprengelmeyer et al. 2006b Ekman faces + Emotion hexagon ○ ○ (●) ● ○ ○  
Premanifest HD 
Tabrizi et al. 2009a Ekman faces (○) (●) (○) (●) (●) (●) (○) 
Key: Ha = happiness; Sa = sadness; Su = surprise; Di = disgust; An = anger; Fe = fear; Ne = neutral 
● = group difference; ○ = no group difference; blank = not tested 
a Composite “negative emotion” score tested 
b Result in brackets only found at timepoint 3 
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3.3.2 Vocal emotion recognition 
In manifest participants an impairment in vocal disgust recognition was found 
consistently (four out of four studies) for both short non-verbal vocal sounds and 
speech prosody.  Anger recognition was found to be impaired in the three studies 
using non-verbal vocal sounds, but not for prosody.  Fear recognition was also found 
to be impaired in three out of four studies, including both non-verbal vocal sounds 
and prosody.  Using prosodic stimuli, impairments were also reported for recognising 
surprise and happiness (Sprengelmeyer et al., 1996) although no other studies 
reported deficits in these emotions. No studies reported a deficit of sadness 
recognition from vocal sounds (Table 3-4
Table 
3-4
). 
Only one study tested vocal emotion recognition in a premanifest cohort 
(Sprengelmeyer et al., 2006) and reported no evidence of impairments at any of three 
timepoints tested, using a combined score from sounds and prosodic stimuli (
). 
3.3.3 Recognition of emotion in other modalities 
Aviezer et al. (2009) found no evidence that their HD population was impaired at 
recognising sad, disgusted or angry body language.  Mitchell et al. (2005) reported 
that their manifest HD cohort tended to rate unpleasant odours and taste 
combinations as less disgusting than controls (Table 3-5). 
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Table 3-4 Vocal emotion recognition results 
Population Study Stimuli Ha Sa Su Di An Fe Ne 
Calder et al. 2010 Non-verbal vocal sounds ○ ○ ○ ● ● ●  
Hayes et al. 2007 Non-verbal vocal sounds  ○  ● ● ○  
Snowden et al. 2008 Non-verbal vocal sounds ○ ○ ○ ● ● ●  
Manifest HD 
Sprengelmeyer et al. 1996 Prosody ● ○ ● ● ○ ●  
          
Premanifest HD Sprengelmeyer et al. 2006 Prosody + non-verbal vocal sounds ○ ○ ○ ○ ○ ○  
Key: Ha = happiness; Sa = sadness; Su = surprise; Di = disgust; An = anger; Fe = fear; Ne = neutral 
● = group difference; ○ = no group difference; blank = not tested 
 
Table 3-5 Emotion recognition in other modalities 
Population Study Stimuli Ha Sa Su Di An Fe Ne 
Aviezer et al. 2009 Body language  ○  ○ ○   
Mitchell et al. 2005 Odours    ●    
Manifest HD 
 Tastes    ●    
Key: Ha = happiness; Sa = sadness; Su = surprise; Di = disgust; An = anger; Fe = fear; Ne = neutral 
● = group difference; ○ = no group difference; blank = not tested 
   
3.3.4 Cross-modal comparisons 
Several studies included tests of emotion recognition in more than one modality, 
although they only report independent statistics for group differences in each 
modality (i.e., they do not directly compare performance between modalities 
statistically).  Aviezer et al. (2009) reported that anger and disgust recognition from 
Ekman faces was impaired in the absence of impairments in recognising emotional 
body language.  Calder et al. (2010) found a global impairment in recognising the six 
canonical emotions from Ekman faces, but only disgust, anger and fear recognition 
were impaired from non-verbal vocal sounds.  A similar pattern was shown by 
Snowden et al. (2008) using the same face stimuli: recognition of all emotions except 
happiness was impaired with facial stimuli, whilst only disgust, anger and fear were 
impaired with non-verbal vocal sounds.  However using a different set of faces 
Snowden et al. (2008) reported impairment only for disgust and anger recognition.  
In the study of Sprengelmeyer et al. (1996) subjects showed impaired recognition of  
surprise, disgust and fear from both facial expressions and prosody, but impaired 
sadness and anger recognition only from facial expressions.  In a premanifest cohort, 
a selective impairment recognising the facial expression of disgust was found in the 
absence of impairments for the other five canonical facial emotions, or any deficits in 
recognising emotions from sounds or prosody (Sprengelmeyer et al., 2006). 
3.3.5 Disproportionate deficits in recognition of specific emotions 
Early reports suggested that HD gene carriers (both manifest and premanifest) were 
disproportionately impaired at recognising disgust, both using faces and prosody 
(Gray et al., 1997; Sprengelmeyer et al., 1996).  Sprengelmeyer et al. (1996) tested 
this statistically, converting manifest HD performance to proportion of controls (to 
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adjust for emotion difficulty) and comparing disgust recognition with the next worst 
recognised emotion, fear.  Disgust recognition was significantly worse than fear 
recognition for both Ekman Faces, Emotion Hexagon, and prosodic stimuli; HD 
participants scored at or below chance level.  Sprengelmeyer et al. (2006) also report 
that in a premanifest cohort facial disgust recognition was the only emotion impaired 
relative to controls, and that 5/12 gene carriers were only impaired at disgust (judged 
by z scores), although the other seven were either unimpaired, or globally impaired.  
Three other studies report selective or disproportionate impairments in disgust 
recognition.  Gray et al. (1997) and Hennenlotter et al. (2004) both found that facial 
disgust recognition was the only emotion impaired in premanifest cohorts, although 
this was not assessed statistically in relation to other emotions.  Hayes et al. (2007) 
reported that more HD participants had z scores of >-1.56 (and more scored at 
chance) for non-verbal vocal disgust recognition than for any other vocal emotion, 
although again, differences between emotions were not assessed statistically. 
Most other studies do not report selective or disproportionate impairments in disgust 
recognition.  Hayes et al. (2009) tested differences between emotions and found no 
evidence that one was more impaired than any other (Ekman Faces and Emotion 
Hexagon).  Henley et al. (2008) compared emotion recognition performance 
statistically (adjusting for control scores) and found recognition of anger to be 
disproportionately impaired (Ekman Faces).  Milders et al. (2003) found that 
recognition of disgust was less impaired than recognition of anger, fear and sadness 
(Ekman Faces).  Snowden et al. (2008) reported either no impairment of disgust 
recognition (Ekman Faces with 2AFC), or that no patient got their worst scores at 
disgust recognition (Ekman Faces with 6AFC); when assessed statistically, disgust 
recognition in their HD group was no worse (and in one case was better) than fear 
 45
   
and anger recognition both for the Manchester faces and eyes set (see section 3.3.1), 
and for non-verbal vocal sounds.  Other studies did not test inter-emotion differences 
statistically but argued that the pattern of findings did not support a disproportionate 
impairment of disgust recognition (e.g., Aviezer et al., 2009; Calder et al., 2010, who 
found a greater number of HD participants impaired at anger across all tasks; 
Johnson et al., 2007; Montagne et al., 2006). 
3.3.6 Within-modality stimulus type comparisons 
Many studies used both the “Ekman Faces” set, as well as the “Emotion Hexagon”.  
Calder et al. (2010) reported similar deficits (across all emotions except happiness) 
with both stimulus sets.  Hayes et al. (2009) found that sadness, surprise, disgust, 
anger and fear recognition were impaired using both the Emotion Hexagon, and 
Ekman Faces at varying intensities, although happiness was only impaired on the 
Ekman Faces set, and no impairment was seen for 25% and 50% sad Ekman Faces.  
Snowden et al. (2008) compared the Ekman Faces set 6AFC, with 2AFC, an 
alternative face set, and eye regions only.  They reported a recognition deficit across 
all emotions except happiness using Ekman Faces, reduced to anger and fear 
recognition deficits when the task was simplified (2AFC), whilst only disgust and 
anger recognition were impaired on the alternative “Manchester” set, and sadness 
and disgust recognition using eye regions only. 
3.3.7 Summary 
Disgust, anger and fear recognition were most often impaired in manifest HD 
populations, across modalities.  For face recognition, the most frequently tested 
modality with the most consistency in stimulus presentation, a deficit in anger 
recognition was found in all the studies in which it was tested.  In premanifest 
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populations deficits were more commonly seen for disgust recognition than any other 
emotion, but only in the facial modality.  Whilst disgust recognition appears 
disproportionately impaired in some HD populations, this is not true of all 
populations tested, nor across modalities.  Outcome varies depending on the type of 
stimulus used (even within a modality). 
4 DISCUSSION 
This review examined 16 studies, investigating emotion recognition in manifest and 
premanifest HD across different modalities.  The discussion will first address 
methodological issues, before going on to draw conclusions and discuss what future 
research is needed, and the clinical implications and limitations of the review. 
4.1 METHODOLOGICAL ISSUES 
4.1.1 Reporting demographic data and results 
Very few studies reported adequate demographic data as well as quantitative results, 
although the studies by Calder et al. (2010), Hayes et al. (2009), Kipps et al. (2007), 
Milders et al. (2003) and Snowden et al. (2008) reported all their results and most of 
the demographic data listed above.  Two studies that reported very little demographic 
data were those of Gray et al. (1997) and Mitchell et al. (2005), although the latter 
author was able to provide age and gender data on request (Mitchell, personal 
communication).  Two studies reported only composite scores (across tasks, 
Sprengelmeyer et al., 2006; across emotions, Tabrizi et al., 2009) which made it hard 
to calculate effect sizes and compare results with other studies. 
One of the biggest weaknesses of the literature is the fact that so few studies report 
sufficient demographic data to allow the HD cohorts to be compared.  Many report 
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either UHDRS motor score, or disease duration, but not both, making it hard to judge 
cohort similarity, and very few report CAG repeat length data, which again would be 
useful in conceptualising how severe or advanced the cohort is likely to be.  
Therefore one major cause of inter-study variability, the inherent heterogeneity in 
HD, cannot be investigated thoroughly, although this would be a useful exercise. 
4.1.2 Choice of control group 
The rationale for using gene-negative or partner controls is that these people live in a 
similar social and emotional environment to people with HD; interacting with family 
members whose emotion recognition, and possibly expression, is impaired may 
impact on the controls’ expression and recognition of emotion, and they are more 
likely than unrelated volunteers to be subject to similar stresses, and therefore have 
similar levels of anxiety and depression.  Use of a gene-negative control group 
therefore aims to minimise group differences attributable to social or emotional 
factors.  One study showed that gene-negative control performance fell below 
published norms at recognising sad, angry and fearful faces from the Ekman 60 set 
(Henley et al., 2008).  Both Sprengelmeyer et al. (2006) and Gray et al. (1997) found 
that their gene-negative control groups performed worse than healthy volunteer 
controls at recognising anger (Ekman Faces and Emotion Hexagon stimuli), although 
in the latter case the additional stress of undergoing genetic testing and being 
unaware of the result may have contributed to poor performance.  Six studies 
(including Gray et al. (1997) whose gene-negative participants were unaware of their 
status) used gene-negative controls, and 10 did not.  It is acknowledged that 
recruiting a gene-negative control group may be more difficult than recruiting 
healthy volunteers.  However, given the evidence cited above that otherwise healthy 
people living in an HD environment show emotion recognition impairments relative 
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to people who are not exposed to those environments, using a gene-negative control 
group may be preferable in order to reduce the likelihood that differences can be 
explained by non-organic disease effects. 
4.1.3 Stimulus type, presentation and response options 
Another potential difficulty in interpreting results across studies is the use of slightly 
different stimulus sets.  The two main tools for assessing facial emotion recognition 
in the literature – the Emotion Hexagon and the Ekman faces – are not of equivalent 
difficulty (based on the mean percent correct achieved by Ekman’s normative 
sample).  In addition, the Emotion Hexagon is not a simple facial emotion 
recognition task.  Morphs of a single subject (“JJ”) were constructed by blending 
different proportions of two emotions, placing each next to one it was most likely to 
be confused with (Calder et al., 1996) although in fact, in order to fit all six canonical 
emotions into the hexagon this is not always true for each pair of emotions.  Blocks 
tend to be repeated in testing which might inflate differences between controls and 
HD subjects if controls benefited from learning over the earlier blocks whilst HD 
subjects did not.  However, based on the literature reviewed here, results using these 
two different sets of facial stimuli are fairly similar (when tested on the same cohort) 
suggesting that results are comparable.  Additionally, limiting presentation time and 
response time did not seem to impact hugely on outcome. 
Interestingly, in the one study that compared the Ekman Faces to a different face set, 
the Ekman set seemed to be harder (Snowden et al., 2008).  All studies except one 
used static black and white faces, which may not be very ecologically valid.  
However the one study to use colour videos had a relatively small HD group and 
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groups were not well-matched for gender, and therefore these results would benefit 
from replication (Montagne et al., 2006). 
There was also a suggestion that different deficits were seen in vocal emotion 
recognition depending on whether non-verbal sounds or prosodic stimuli were used.  
However far fewer studies have tested vocal emotion recognition (compared with 
face emotion recognition), and prosodic stimuli have only been used in one manifest 
and one premanifest cohort, so these results would also benefit from replication.  
Sprengelmeyer et al. (2006) stated that scores on non-verbal vocal and prosodic 
stimuli in their premanifest cohort were correlated, and therefore presented a 
composite score (using which there was no evidence of impairment).  However it 
would be interesting to compare the two stimulus sets directly in the same cohort to 
begin to ascertain whether deficits vary depending on stimulus type. 
4.1.4 Statistical analysis 
Only two studies considered issues of power and sample size, both stating that they 
were powered adequately to detect relatively small effects (Johnson et al., 2007; 
Tabrizi et al., 2009).  Sample sizes in some of the other studies were relatively small 
(in some cases fewer than 10 participants in the HD group) which raises the question 
of whether some studies, particularly of premanifest populations where effects are 
likely to be small, were under-powered. 
Most, although not all, control and HD groups were said to be matched for 
demographic variables such as age, gender, and in some cases IQ or educational 
level.  However, non-statistically significant group differences in these variables 
does not mean that small differences cannot still influence outcome on another 
variable.  Johnson et al. (2007) show that age, gender and education have 
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independent effects on recognition of some emotions, which, on average, decreases 
with increasing age and less education, and is better in females than in males.  There 
is also evidence that fear and anger recognition might deteriorate with age, whilst 
disgust recognition is relatively spared (Calder et al., 2003).  The original finding of 
impaired disgust recognition in HD used controls who were on average five years 
older than HD subjects, and did not adjust for the effects of age (Sprengelmeyer et 
al., 1996), and so it may be that this group difference inflated the effect. 
It is notable that although a number of studies included the Benton Facial 
Recognition Test as a “background measure”, few took these results into account in 
their analysis.  Several studies reported that, on average, HD groups performed worse 
than control groups at this test, and in many cases were in the “borderline range”.  In 
fact examination of mean (SD) face recognition scores (where available) suggests 
that some HD participants may even have been moderately or severely impaired (and 
data provided by Aviezer et al. (2009) and Gray et al. (1997) confirm this to be the 
case even when no statistically significant group differences were found).  This 
means that some group differences on facial emotion recognition may in fact be 
attributable to poorer face processing in some HD participants. 
Where auditory stimuli were used, no study reported background tests of audition.  
Auditory stimuli are also naturally transient, unlike visual stimuli which (in many 
studies) remained present until a response was made.  However no study reported 
making allowances for the potential demands on working memory this makes by, for 
example, allowing participants to hear auditory stimuli more than once if needed. 
Two statistical issues that arise continually in this field are those of non-normally 
distributed data (groups often perform at ceiling on happiness recognition, for 
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example) and carrying out multiple statistical comparisons.  Larger, and more recent 
studies tended to manage non-normally distributed data better, whilst earlier and 
smaller studies often did not, which makes the robustness of their findings 
questionable.  The issue of multiple comparisons is solved in different ways: 
sometimes by using Bonferroni-type corrections (although most studies that use this 
method only control the false positive rate within a particular test, rather than across 
all the tests reported in the study), and sometimes by simply acknowledging the 
problem and reporting uncorrected statistics nevertheless.  However, with the current 
body of literature meaning that many findings have been replicated, it is possible to 
feel more confident about which findings are consistent and which are less so.  In 
addition, where studies make their mean (SD) results available, it is possible to 
compare effect sizes between studies. 
4.1.5 Summary 
Overall, the quality of the studies included in the review was variable, ranging from 
very small (<10 per group) studies, in which possible confounds were not always 
taken into account and data distribution was not considered in the analysis, to much 
larger (>100 per group) studies which were adequately powered to detect small 
effects, and adjusted for a number of potential confounds in their analysis.  In terms 
of outcome, the most robust results are likely to be those from the studies that were 
adequately powered and in which consideration was given to data distribution and 
confounding variables prior to analysis.  The use of a gene-negative control group is 
also likely to influence outcome.  Based on this assessment, the most robust studies 
are likely to be the two large longitudinal studies, PREDICT-HD and Track-HD 
(Johnson et al., 2007; Tabrizi et al., 2009), as well as by those medium- or small-
sized studies whose analysis took into account confounds, and data distribution 
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(Henley et al., 2008; Kipps et al., 2005; Snowden et al., 2008; Sprengelmeyer et al., 
2006).  In the discussion that follows, more weight is given to findings from those 
studies that were assessed as being of higher quality. 
4.2 CONCLUSIONS 
4.2.1 Facial emotion recognition 
Using facial stimuli, anger recognition was most consistently impaired in manifest 
HD populations, closely followed by disgust and fear.  Sadness and surprise were 
less consistently affected, and happiness very rarely.  In premanifest populations 
there was sometimes no detectable deficit, sometimes facial disgust recognition was 
the only impairment seen, and in two studies impairment was seen across all negative 
emotions.  Undoubtedly facial emotion recognition performance gets worse as 
populations move from being premanifest to manifest.  Because either CAG repeat 
data or some measure of disease severity (e.g. UHDRS motor score, or disease 
duration) were not reported by a number of studies it is hard to ascertain whether an 
increasingly broad, or simply a more severe impairment is associated with more 
advanced disease (although some studies examine this within a single cohort (e.g., 
Johnson et al., 2007)).  Three studies lend evidence to the suggestion that facial 
disgust recognition is the earliest emotion and modality to be affected, and that 
therefore deficits become broader as disease progresses (Gray et al., 1997; 
Hennenlotter et al., 2004; Sprengelmeyer et al., 2006).  However the two studies 
judged to be of the highest quality report that wider deficits are detectable even in 
very early premanifest participants (Johnson et al., 2007; Tabrizi et al., 2009); one 
specifically states that disgust recognition is no more impaired than the other 
negative emotions (Johnson et al., 2007).  This lends support to the idea that all 
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negative emotions are affected from an early stage, and that impairments then worsen 
across emotions as disease progresses.  Certainly in manifest cohorts the majority of 
studies find no evidence that facial disgust recognition is disproportionately impaired 
compared with other negative emotions.  Overall evidence suggests that negative 
emotions are more impaired than positive / ambiguous (happiness and surprise), and 
that this impairment progresses with disease, but can be detected in all negative 
emotions even in very early premanifest participants. 
4.2.2 Vocal emotion recognition 
Vocal emotion recognition has been studied far less, but the overall picture is similar.  
In manifest cohorts disgust recognition is consistently impaired, although anger and 
fear are often impaired as well.  Two studies find that the disgust impairment is 
greater than that for other emotions (Hayes et al., 2007; Sprengelmeyer et al., 1996) 
but two find that anger or fear are affected more than disgust (Calder et al., 2010; 
Snowden et al., 2008).  The one study investigating this in a premanifest group found 
no evidence of any deficits across emotions; thus as with faces there is no convincing 
evidence that vocal disgust recognition is affected more, or earlier, than other 
emotions.  Unlike facial emotion recognition, no impairments have been found for 
vocal sadness recognition.  On average, participants who could recognise vocal 
sadness were impaired at recognising facial sadness.  It may be that sadness is easier 
to recognise vocally than facially, or that different modalities are differentially 
affected in HD.  However, no study tested inter-modality differences statistically, 
and evidence of a significant group difference in one modality, but not in another, is 
not in itself evidence that performance in one modality is significantly different to 
performance in another.  Further inter-modality work will be needed to clarify this. 
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4.2.3 Recognition of emotion in other modalities 
Few studies looked at modalities other than faces or voices.  Snowden et al. (2008) 
included an “eyes only” stimulus set, which in this review has been discussed 
separately from faces, because of the different information available in such stimuli.  
Whereas when using entire faces, disgust and anger recognition were impaired, when 
using only eyes anger recognition was unimpaired and sadness was impaired.  This 
might suggest that angry faces are more easily disambiguated when non-eye 
information is hidden, whereas the opposite is true for sadness, which perhaps relies 
more on the lower half of the face.  As this is a single study it would benefit from 
being replicated. 
One study looked at body language and found no evidence of impaired emotion 
recognition (Aviezer et al., 2009).  However some of the body language stimuli 
contained semantic clues (dirty underwear for disgust, and a gravestone for sadness).  
It is therefore possible that people with HD were able to label the images based on 
previously acquired semantic knowledge, rather than recognition of the emotion 
conveyed by the body postures of the models.  One study looked at the odour and 
taste domains, although necessarily only tested disgust in these domains (Mitchell et 
al., 2005).  After failing olfactory screening, two participants were dropped from the 
odour tests, but retained in the taste test, although there is evidence that flavour 
discrimination also depends on odours and therefore it is questionable whether these 
two participants should have remained in the study at all (Schiffman & Gatlin, 1993).  
This study shows that participants with HD tended to rate disgusting odours and taste 
combinations as less disgusting than controls.  However this study differs from those 
in the facial and vocal domains to some extent as it is asking for subjective ratings, 
rather than categorisation of an external stimulus.  Mean ratings suggest that 
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participants with HD were still able to discriminate between pleasant and less 
pleasant stimuli, so these results may represent a dulling of subjective sensations, 
rather than an inability to recognise objectively that odours and tastes might be 
categorised as “disgusting”. 
4.3 FUTURE RESEARCH 
Future research would benefit from focusing on a number of areas.  Firstly, 
improving study quality and consistency, for example by reporting sufficient 
demographic data to allow cohorts to be compared, and by careful consideration of 
possible confounds, and appropriate statistical analysis.  There could also be more 
consistency with stimulus presentation (particularly in the facial recognition domain) 
although subtle differences in stimulus sets and presentation did not seem to lead to 
large differences in outcome in the studies reviewed here.  Perhaps more important is 
the finding that using completely different (non-Ekman) stimulus sets results in 
different findings.  Only one study attempted to use more ecologically valid facial 
stimuli (colour videos) and this seems to be a major gap in the field.  In addition, 
most studies use verbal labelling as their response of choice (some studies use 
within-modality stimulus matching but this was not considered a sufficiently robust 
test of emotion recognition for inclusion in this review).  It would be interesting to 
test between-modality stimulus-matching as an alternative to verbal labelling.  Also, 
future work should certainly include tasks in more than one modality in order to test 
statistically whether impairments in one modality are different to those seen in 
another, as currently there is no clear evidence on this. 
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4.4 CLINICAL IMPLICATIONS 
There is currently a large body of research investigating potential biomarkers and 
endpoints for clinical trials in HD.  One of the implications from these findings is 
that emotion recognition may be of potential use as a biomarker.  Emotion scores 
(both composites and individual emotions) are already included in the two largest 
ongoing longitudinal studies, PREDICT-HD (Paulsen et al., 2006) and Track-HD 
(Tabrizi et al., 2009) and further work should demonstrate how sensitive emotion 
recognition is at tracking decline over time, relative to other potential markers. 
On an individual level, these results clearly show that in people with manifest HD 
emotion recognition tends to be impaired across negative emotions, in at least the 
facial and vocal domains, and that subtle impairments can be detected many years 
before motor onset.  Anecdotally, carers and spouses often report that their partner 
with HD seems to react inappropriately when they are portraying emotions: one 
spouse told the first author that she was discussing something very upsetting with her 
husband, and he responded by talking about a new car he wanted to buy; another 
reported that whilst his wife got angry easily, she no longer seemed to recognise 
when he was angry, and to get her to appreciate his mood he needed to be explicit 
about his feelings and explain why he felt them.  Whilst it seems clear that one of the 
main difficulties caused by poor emotion recognition would be social interaction, 
there is little formal evidence of how these difficulties impact on the relationships of 
people with HD.  The research reviewed here also raises the question of whether the 
difficulties people with HD have with facial emotion recognition are as severe, or 
affect the same emotions, as those seen when non-verbal vocal stimuli, or prosodic 
stimuli are used.  Both these areas would benefit from more research, firstly in order 
to outline the impact that these difficulties have, and secondly to investigate what 
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strategies might go some way towards overcoming them.  For example, if people 
with HD can recognise an emotion better in one modality than another, carers could 
use this knowledge to help them judge how best to get their feelings across.  
Currently the literature does not address either of these questions adequately. 
4.5 LIMITATIONS 
This review was limited to peer-reviewed publications, meaning that grey literature 
and unpublished data were not included.  Whilst this ensures some level of 
methodological rigour, in that all the studies have gone through the peer-review 
process, publication bias may mean that studies that did not find deficits in emotion 
recognition have been overlooked.  Although efforts were made to clarify queries 
with corresponding authors of all the included studies, some were not contactable.  
This means that some data queries have gone unanswered, as have requests for extra 
demographic or outcome data. 
5 CONCLUSION 
The literature currently supports the conclusion that vocal and facial negative 
emotion recognition is impaired in both premanifest and manifest Huntington’s 
disease, and suggests that impairments worsen with disease progression.  There is yet 
to be convincing evidence of disproportionate impairments in particular emotions, 
and it is unclear whether impairments in one modality are of greater severity than 
those in another.  Future work could usefully focus on developing more ecologically-
valid stimulus sets and comparing performance between modalities directly, in order 
to answer some of the questions that still remain with regards to the deficits seen in 
this population.  As neuropsychological metrics of clear relevance to patients’ 
everyday lives, there is an overarching need further to evaluate emotion processing 
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measures as potential biomarkers for symptomatic and disease-modifying therapies 
in this devastating disease.  
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PART 2: EMPIRICAL PAPER 
EMOTION RECOGNITION IS IMPAIRED ACROSS MODALITIES IN 
MANIFEST HUNTINGTON’S DISEASE 
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ABSTRACT 
Aims 
Huntington’s disease (HD) is known to cause impaired emotion recognition, 
particularly in the facial domain.  Emotion recognition in other domains has been 
less well studied.  No study has compared formally emotion recognition performance 
in more than one modality.  The aim of this study was to assess emotion recognition 
in early HD using a range of modalities (facial, vocal and musical), in order to 
examine whether impairments were cross-modal. 
Methods 
Twenty-five participants with early HD (CAG repeat length>38) were compared 
with 25 neurologically-normal controls on a range of measures including estimated 
pre-morbid IQ, executive function, facial recognition, music perception, and emotion 
recognition.  In each of three modalities (faces, voices, music) 10 stimuli for each of 
four emotions were presented and participants asked to select a response from 
“happy”, “sad”, “angry” or “fearful”. 
Results 
After adjusting for age, estimated pre-morbid IQ, facial recognition skills, executive 
function and gender, the HD group was impaired relative to controls at recognising 
sad, angry and fearful stimuli in all three modalities.  There was a tendency for the 
HD group to find fearful faces and voices harder to recognise than sad or angry faces 
and voices, after adjusting for control performance.  There was also evidence that the 
HD group found fearful faces and voices harder to recognise than fearful music. 
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Conclusions 
The emotion recognition impairment in HD appears to be cross-modal, suggesting 
the involvement of relatively high-level neural systems, rather than modality-specific 
mechanisms.  Possible neural substrates are discussed, as well as the implications for 
the symptomatic management of the disease. 
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1 INTRODUCTION 
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder 
caused by an expanded CAG repeat on chromosome 4.  It is classically characterised 
by involuntary movements, and cognitive and psychiatric deficits, with the onset of 
motor signs usually occurring in mid-adulthood.  Although for many years it was 
characterised primarily as a movement disorder, it is now well recognised that 
cognitive and psychiatric problems accompany and frequently precede motor signs 
(Lawrence et al., 1998; Snowden, Craufurd, Thompson, & Neary, 2002).  It has a 
prevalence in the UK of  ~1 per 10,000 individuals with many more at risk of the 
disease (Harper, 2002).  It progresses slowly and inexorably, with increasingly 
distressing and disabling symptoms associated with considerable care-giver and 
family burden, with morbidity and death occurring 15-20 years from onset, by which 
time the patient is often bed-bound and mute.   
Recognising emotions in others is an important social skill, and much work has been 
done on studying the expression and recognition of canonical emotions which appear 
to be cross-cultural, and which it is argued have a biological basis (Ekman, 1992).  
Deficits in emotion recognition have been reported in both premanifest (prior to 
motor onset, PM) and early HD.  Originally facial disgust recognition was thought to 
be particularly impaired (see, for example, Gray, Young, Barker, Curtis, & Gibson, 
1997; Montagne et al., 2006; Sprengelmeyer et al., 1996).  It has also been suggested 
that disgust recognition is similarly impaired in the vocal, olfactory and gustatory 
domains (Hayes, Stevenson, & Coltheart, 2007; Mitchell, Heims, Neville, & 
Rickards, 2005; Sprengelmeyer et al., 1996).  However more recently larger studies 
have failed to replicate the finding of disproportionately impaired facial disgust 
recognition, showing instead an impairment across negative emotions (sadness, 
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disgust, anger and fear) and occasionally showing most impairment at fear or anger 
recognition (Aviezer et al., 2009; Henley et al., 2008; Johnson et al., 2007; Milders, 
Crawford, Lamb, & Simpson, 2003; Snowden et al., 2008). 
A systematic review of the literature (Henley et al., in press) supports the conclusion 
that in manifest HD emotion recognition is impaired fairly consistently across all 
negative emotions in the facial domain.  Far fewer studies have investigated vocal 
emotion recognition, and those that have find that disgust recognition is impaired 
most often (four out of four studies) but that anger and fear recognition are often 
impaired as well.  Although some studies have looked at facial and vocal emotion 
recognition in the same cohort, to date no study has carried out direct statistical 
comparisons of performance in different modalities, so it is not clear whether cross-
modal deficits are of similar magnitudes.  In addition, very few studies have 
attempted to assess emotion recognition in modalities other than facial and vocal. 
It is unclear why relatively few studies have focused on vocal emotion recognition in 
HD, nor why there have been no direct comparisons of facial and vocal emotion 
recognition.  Deficits in recognising emotional prosody in HD were first reported in 
1990 (Speedie, Brake, Folstein, Bowers, & Heilman) and one of the earliest studies 
investigating emotion-specific impairments in HD included both facial and vocal 
stimuli (Sprengelmeyer et al., 1996).  As with facial expressions, canonical vocal 
emotional expressions are recognised cross-culturally, and very rapidly (Sauter & 
Eimer, 2010; Sauter, Eisner, Ekman, & Scott, 2010).  Vocal and facial emotion 
recognition of specific emotions are thought to depend on similar neural substrates 
including, for example, insula-striatal systems for disgust, amygdala for fear, ventral 
striatum for anger (Adolphs, 2002; Calder, Keane, Lawrence, & Manes, 2004; 
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Calder, Keane, Manes, Antoun, & Young, 2000; Calder, Lawrence, & Young, 2001).  
Within HD research several studies have used structural or functional imaging to 
examine the neural substrates underlying facial emotion recognition (Henley et al., 
2008; Hennenlotter et al., 2004; Kipps, Duggins, McCusker, & Calder, 2007) and 
have found similar brain regions to be implicated.  It would therefore be predicted 
that the facial emotion recognition deficits seen in HD should also be seen in other 
modalities (including vocal); indeed based on current neurological evidence it might 
seem unusual if such deficits were not cross-modal. 
Music is another modality through which emotion can be expressed (Krumhansl, 
1997).  Musical stimuli have tended to be underrepresented in formal studies of 
emotion recognition, perhaps because of a belief that the ability to perceive emotions 
in music is a relatively recent phenomenon in human development, based on purely 
aesthetic features, rather than evolving as a useful survival mechanism as recognition 
of emotions in faces and voices may have done.  However, there is increasing 
evidence that listening to music is associated with activation patterns in brain regions 
that are implicated in general reward and emotion perception, such as the ventral 
striatum, amygdala, prefrontal cortex and insula (Blood & Zatorre, 2001; Brown, 
Martinez, & Parsons, 2004; Griffiths, Warren, Dean, & Howard, 2004).  In a recent 
review Koelsch (2010) argues that in fact music emotion recognition has evolved to 
have social “survival” value, for example helping humans to achieve goals of 
communication, collaboration, and playing a role in social cohesion and reciprocal 
care; hence it is unsurprising that recognition of emotion in a relatively abstract 
stimulus (music) seems to use, in a large part, similar neural networks as recognition 
of emotions in other modalities.  Indeed, several of these brain areas (the so called 
“social brain”) are consistently activated in theory of mind and empathy tasks, tasks 
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in which participants are required to represent the state of the world around them, 
and emulate the feelings of others (Dodell-Feder, Koster-Hale, Bedny, & Saxe, 2011; 
Singer, 2006).  Music is also by its nature a relatively abstract representation of 
emotion and may therefore depend on more abstract reasoning abilities (and 
underlying neural substrates) than face and vocal emotion processing. 
People with little or no formal musical training are consistent, and very rapid, in their 
emotional ratings of classical music into basic emotional categories (Peretz, Gagnon, 
& Bouchard, 1998).  There is also some evidence that even when musical perceptual 
processing is impaired by acquired brain damage (e.g. the ability to recognise 
excerpts, and detect differences in pitch and rhythm are lost), musical affective 
processing can be spared (Peretz et al., 1998).  This suggests that it is not necessary 
to be either highly trained, or to have intact musical perceptual systems in order to 
appreciate the emotional content of music.  In addition, there is at least one report of 
an individual whose musical perceptual processing was within normal limits, but 
who reported an inability to experience as pleasurable music he had enjoyed prior to 
a left hemisphere infarct (Griffiths et al., 2004).  This lends support to the idea that 
systems for processing the affective value of music might be functionally and 
anatomically distinct from those needed to process the perceptual characteristics. 
The fact that similar neural substrates may underlie both music emotion processing 
and recognition of emotions in more biologically-relevant stimuli such as faces and 
voices suggests that music emotion recognition may merit further examination.  In 
populations with a neurodegenerative disease, many of the brain regions implicated 
in emotion recognition are compromised, and deficits in music emotion recognition 
have previously been reported in populations with fronto-temporal lobar 
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degeneration (Omar et al., 2011) and Parkinson’s disease (van Tricht, Smeding, 
Speelman, & Schmand, 2010).   
Given the locus of atrophy in early HD (marked in the striatum, with evidence that 
frontal and other cortical areas are more mildly affected until later stages (see e.g., 
Tabrizi et al., 2009)), and previous behavioural evidence, we would predict that 
emotion recognition would be impaired across facial, vocal and musical modalities.  
However, as mentioned above, the extent to which impairments in one modality are 
comparable to those in another has not yet been ascertained.  In HD, the question of 
the extent to which any deficit seen is uniform across modalities is an important one.  
Not only does this have implications for the neural substrates involved, but would 
also impact on potential symptomatic treatments.  Although there is little formal 
research in this area, anecdotally carers often report how distressing they find it when 
their emotions go unrecognised and unacknowledged by people with HD.  If 
recognition of some emotions was shown to be spared in one modality relative to 
another, information from the former modality might be used successfully to 
partially alleviate the difficulties people with HD have in the others.  The aim of the 
current study was therefore to compare directly facial, vocal and musical emotion 
recognition in the same cohort of HD participants.  This could have important 
implications for our understanding of the experience of people with HD, and for 
symptomatic treatment of the disease, as well as adding to the body of evidence 
about the similarities between emotion recognition performance with faces and 
voices, and the more abstract stimulus of music. 
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2 METHODS 
2.1 PARTICIPANTS 
Twenty-five patients with genetically-confirmed HD were recruited from the 
multidisciplinary HD clinic at the National Hospital for Neurology and 
Neurosurgery, London, the Institute of Neurology HD Research Database and the 
Huntington’s Disease Clinic at Addenbrooke’s Hospital, Cambridge.  All patients 
had a CAG repeat length of >38 and were clinical stage 1 or 2 as determined by 
functional assessment (Shoulson & Fahn, 1979).  Twenty-five neurologically-normal 
controls, who comprised either the patients’ partners or at-risk subjects who had 
tested negative for the HD gene expansion, were also recruited.  Such controls are 
more likely to experience similar social and environmental influences to HD gene 
carriers than healthy volunteers from the general population, and therefore these 
factors are less likely to play a role in group differences.  Participants with a history 
of substance abuse, estimated pre-morbid IQ of below 80, or significant medical, 
neurological or psychiatric comorbidity (non-HD related) were excluded.  No 
participant reported a hearing difficulty.  All participants gave written informed 
consent in accordance with the Declaration of Helsinki, and the study had local 
research ethics committee and UCLH NHS Trust approval (see Appendix 3). 
Twenty-five participants (16 early HD and nine controls) were initially recruited as 
part of the London Longitudinal HD study and the relevant neuropsychological data 
were collected, by the author, as part of that study (see e.g., Henley et al., 2009).  
However the emotion recognition data presented here have not been presented 
elsewhere prior to this.  An additional 25 participants were recruited for the current 
study. 
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2.2 SAMPLE SIZE 
Previous studies of facial emotion recognition have found large (d>0.8) effect sizes 
(Cohen, 1992) when comparing recognition of fear and anger between early HD and 
controls using the Ekman pictures of facial affect (e.g., Henley et al., 2008; Milders 
et al., 2003), when using vocal stimuli (Sprengelmeyer et al., 1996) (although this 
study used a different set of stimuli to those in the current study) and when using the 
music emotion stimuli described here (Omar et al., 2011) (in a cohort with fronto-
temporal lobar degeneration).  Most studies fail to find evidence of an impairment in 
happiness or sadness recognition (in any modality) although it was deemed important 
to include these stimuli as comparisons and to keep the nature of the test similar to 
previous work. 
For the purposes of this study sample size calculations focused on anger and fear 
recognition in the three modalities and were based on effect sizes derived from the 
above studies.  These studies differed in key ways from the one proposed here 
(particularly in the nature of the behavioural test, and the demographics of the 
cohorts tested) and this must be taken into account when estimating sample sizes.  
Sample sizes were calculated for logistic regression with a single binary predictor (in 
this case group) with α=0.05 (one-tailed) and power=0.7 using GPower 3.1 (Faul, 
Erdfelder, Lang, & Buchner, 2007).  Given the exploratory nature of the study and 
the fact that this test is novel, 70% power was deemed appropriate at this stage.  If 
effect sizes turn out to be as predicted then follow-up work could be planned with 
increased power.  The correlation between gender, age, IQ and group in the above 
studies was minimal (and should be in the planned study) and so the variance 
inflation factor (R2 for other covariates) was estimated at 0.05 (Hsieh, Bloch, & 
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Larsen, 1998).  Based on the above studies, estimated proportions correct were 90% 
in controls, and 50% in HD for facial and vocal stimuli, and 75% in controls and 
30% in HD for music stimuli.  Estimates for sample sizes in each group were 24 
(music stimuli) and 25 (facial and vocal stimuli) (Faul et al., 2007).  Given the 
exploratory nature of the study, a sample size of 25 in each group was therefore 
decided on.  This should mean that the study is powered adequately to detect 
statistically significant group differences in emotion recognition, assuming large 
effect sizes. 
2.3 MEASURES 
All HD participants had previously been assessed by neurologists using the standard 
neurological test for HD (Unified Huntington’s disease rating scale, UHDRS 
(Huntington Study Group, 1996)) and consented to these data being used in the 
current study to provide information about their disease state.  The current battery 
included tests of facial, vocal, and musical emotion recognition, as well as 
background tests of potential confounding variables such as estimated pre-morbid 
IQ, executive function, face recognition, music perception and musical knowledge as 
follows: 
2.3.1 Estimated-premorbid IQ 
Pre-morbid IQ was estimated using the National Adult Reading Test (NART) 
(Nelson & Willison, 1991). 
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2.3.2 Executive function 
The Trail-Making Test (Reitan & Wolfson, 2004) (time to complete Part B minus 
time to complete Part A) was used as a measure of “executive function”, in this case 
set-switching, which is known to be affected in HD. 
2.3.3 Facial recognition 
Face recognition was tested using the short form of the Benton Facial Recognition 
Test (Benton, Hamsher, Varney, & Spreen, 1983). 
2.3.4 Musical perception 
Music perception was assessed using the Montreal Battery of Evaluation of Amusia 
(MBEA), for which age-matched normative data are available for musically 
untrained subjects (Peretz, Champod, & Hyde, 2003). This battery is based on a two 
alternative (same/different) forced choice comparison of pairs of short unfamiliar 
musical sequences. Four subtests of the MBEA were used: scale (key), pitch contour 
(melody), pitch interval, and rhythm.  As this battery was not available to 
participants who were assessed as part of the London Longitudinal HD study, it was 
only possible to assess music perception in a subset of participants (14 controls and 
eight early HD) who were recruited more recently. 
2.3.5 Musical background 
Musical background was measured using the Hailstone Questionnaire (Hailstone et 
al., 2009) (see also Appendix 4).  This questionnaire was not available for five of the 
earliest-tested London Study participants.  Data on participants’ musical background 
is presented in Appendix 5. 
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2.3.6 Emotion recognition 
A novel battery was designed to assess recognition of four emotions (happiness, 
sadness, anger, fear) in music, for comparison with recognition of these emotions 
from facial expression and nonverbal vocal sounds.  The target emotions chosen 
represent four of the six canonical emotions in the original set of emotional faces 
created by Ekman and Friesen (1976); surprise and disgust were excluded due to the 
difficulty of creating musical equivalents for these.  The novel battery has previously 
been described and used with participants with a diagnosis of fronto-temporal lobar 
degeneration (Omar et al., 2011; Omar, Hailstone, Warren, Crutch, & Warren, 2010). 
2.3.6.1 Stimuli: music 
The stimuli for recognition of emotion in music were excerpts drawn from the 
Western classical canon and film scores (mean duration (range) as follows:  anger 
11.6 sec (9.8 – 13.3); fear, 12.2 sec (10.3 – 16.4); happiness, 10.5 sec (8 – 13.3); 
sadness, 11.6 sec (10.1 – 16.0)). Stimuli were selected for inclusion in the battery 
based on an initial pilot study (described in Appendix 6) in 16 healthy participants 
who did not participate in any subsequent experiments.  Most pieces were orchestral 
works; some chamber pieces are also included.  Songs and other vocal musical 
pieces were excluded to avoid confounding from primarily vocal emotion processing.  
Stimuli are available on the CD submitted with this thesis. 
2.3.6.2 Stimuli: facial expressions 
The facial emotion stimuli comprised black and white photographs of posed facial 
expressions derived from the set produced by Ekman and Friesen (1976); the most 
reliably recognised exemplars from the original set for each target emotion were 
selected. 
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2.3.6.3 Stimuli: nonverbal vocal sounds 
The vocal emotion stimuli were brief nonverbal vocalisations recorded by male and 
female actors to express each of the same target canonical emotions (Sauter, 2006).  
The most reliably recognised exemplars from the original set for each target emotion 
were selected. 
2.3.6.4 General testing procedure 
Stimulus presentation was on a notebook computer in a quiet room, free from 
distraction.  Cogent 2000 (www.vislab.ucl.ac.uk/Cogent2000) running under 
MATLAB 7.0® (http://www.mathworks.com) was used for stimulus presentation, 
with participant responses collected for off-line analysis. 
Each trial consisted of stimulus presentation, with simultaneous presentation of the 
four target emotion words in a random order at the corners of the screen, i.e. a four-
alternative forced-choice (4AFC) paradigm.  Visual stimuli (Ekman faces) were 
centred on the screen, and remained on screen until a response was made.  Auditory 
stimuli were presented as digital wave files in free field at a comfortable listening 
level.  Participants could choose to repeat auditory stimuli as many times as they 
wished prior to making a response.  In both visual and auditory trials the target 
emotion words remained on screen throughout the trial.  Vocal stimuli were on 
average two seconds long, and musical stimuli were on average 11 seconds long.  
Each target emotion word was presented next to a number from 1-4.  Participants 
responded orally when they had made a choice, and the examiner entered the 
numbered button-press corresponding to the participant’s response.  Examiner 
button-press, rather than participant button-press, was used because prior experience 
with this population showed that the motor symptoms of HD could in cases affect 
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button-press accuracy.  A trial ended only when the participant choice had been 
entered by the examiner (i.e. trials were not time-limited).  At this point a blank 
screen was displayed for 2 seconds prior to the next trial. 
For each modality 40 trials were presented, comprising 10 stimuli representing each 
of the four target canonical emotions.  Modalities were presented in a block design, 
in the order: faces, vocal sounds, music. Within each modality (block), the 40 trials 
were presented in randomised order.  For the music block participants were also 
asked whether the stimulus was familiar or not.  Before the start of each modality 
block, four practice trials were administered to ensure the participant understood the 
task.  No feedback about performance was given during the test. 
2.4 PROCEDURES 
Neuropsychological tasks were administered by the same investigator in a single 
session lasting approximately 2 ½ hours, either at UCL Institute of Neurology, or at 
the participant’s home. 
2.5 STATISTICAL ANALYSIS 
Data were analysed using STATA version 9.2 (Stata Corporation, College Station, 
Texas, 2006). 
2.5.1 Demographic and background data 
A Chi-square test was used to examine whether gender differed between groups and 
Fisher’s exact test was used to examine whether handedness differed between 
groups.  t-tests, allowing for unequal variance where necessary, were used to 
investigate group differences in age and estimated premorbid IQ. 
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Fisher’s exact test was used to compare the proportion in each group that had failed 
the Benton test and the Peretz test.  A t-test, allowing for unequal variance, was used 
to compare group means on the Benton (this test is already age- and education-
adjusted). 
As the Trail-Making scores were not Normally distributed, linear regression models 
were used to assess group differences, with 95% accelerated bias-corrected bootstrap 
confidence intervals, with 2000 replicates, adjusting for the effects of age and 
estimated pre-morbid IQ by including them as covariates.  A linear regression model 
was used to assess group differences in Peretz score, again adjusting for the effects of 
age and estimated pre-morbid IQ by including them as covariates.  Adjusted 
between-group differences are reported here, with unadjusted between-group 
differences reported in Appendix 7 for comparison.  The model assumes that 
adjusted between-group differences are constant for all levels of the covariates 
adjusted for, i.e. the adjusted between-group differences reported are independent of 
the level of the nuisance covariate. 
2.5.2 Emotion recognition data 
2.5.2.1 Differences between groups 
Generalised linear mixed regression models were used to investigate the influence of 
group, modality, target emotion and their interactions on the probability of a correct 
response. A logistic link was used as is standard for binary outcomes (intended 
versus other response) and subject identity was included as a random effect to allow 
for associations between responses from the same individuals.  The effects of age, 
estimated pre-morbid IQ, facial recognition ability (Benton), executive skills (Trail-
Making Tests B minus A) and gender were adjusted for by including these variables 
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as covariates in the model.  Adjusted odds ratios are reported here, with unadjusted 
odds ratios reported in Appendix 7.  Within each modality (faces, voices and music) 
and emotion (happy, sad, angry, fearful) the odds of an intended response relative to 
that for controls were estimated (i.e. performance in the early HD group was 
compared with that of controls, for each emotion within each modality).   
2.5.2.2 Modality- and emotion-dependent differences in the HD group 
Where there was evidence of impairment in the early HD group relative to controls 
further planned comparisons were carried out.  Recognition of different emotions 
was compared within each modality, to investigate whether there was evidence that 
some emotions were harder to recognise than others.  Recognition of each emotion 
was also compared across the three modalities, to investigate whether there was 
evidence that recognition of a given emotion was harder in some modalities than 
others.  For all these secondary analyses control performance was taken into account, 
to allow for normal differences in the recognition of different emotions in different 
modalities; thus, for example, the odds of an intended angry response to faces in 
early HD relative to controls was compared with the odds of an intended fear 
response to faces in the early HD group relative to controls. 
Significance levels were not adjusted to take into account the number of comparisons 
because all the associations being investigated were thought to be of independent 
scientific interest (Rothman, 1990).   
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3 RESULTS 
3.1 DEMOGRAPHIC DATA 
Demographic data are shown in .  Differences in gender, age, handedness 
and estimated pre-morbid IQ between the HD and control groups were small and 
non-significant (all p>0.05).  The majority (23) of HD patients underwent 
neurological assessment within the year prior to cognitive testing.  Neurological data 
for two HD patients were only available from 1.5 and 2 years prior to cognitive 
testing and are therefore likely to underestimate severity in these two patients. 
Table 3-1
Table 3-1 Demographic data 
 Control 
(N=25) 
HD 
(N=25) 
Gender (M:F) 13:12 11:14 
Age, years 48.9 (13.7) 54.0 (10.6) 
Estimated premorbid IQ 109.8 (12.2) 108.7 (11.7) 
Handedness (R:L) 23:2 21:4 
CAG repeat length  42.8 (2.0), range 39 - 46
Duration of motor signs, years  6.4 (3.5) 
UHDRS Motor  34.5 (14.9) 
UHDRS Independence  88.6 (11.9) 
UHDRS Total Functional Capacity  10.2 (2.2) 
Data are shown as mean (s.d.) with the exception of gender and handedness; handedness was taken as 
the hand used to write with; UHDRS = Unified Huntington’s Disease Rating Scale: motor is out of 
124, higher score = more severely impaired; independence is scored as a percentage, higher score = 
better function; Total Functional Capacity is out of 13, higher score = better function 
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3.2 BACKGROUND DATA 
Five HD participants failed the Benton Facial Recognition Test, compared with no 
controls, a result of borderline statistical significance (p=0.050, Fisher’s exact test).  
On average the HD group scored significantly lower than controls on the Benton 
(mean difference 3.0 points, 95% CI -5.3, -0.7, t(48)=2.60, p=0.013).  After adjusting 
for age and IQ the HD group was also slower, on average, to complete the Trail-
Making Test A and Trail-Making Test B, than controls: TMTA mean difference 14.2 
seconds, Bootstrap 95% CI 9.3, 21.4, p<0.05; TMT B mean difference 70.9 seconds, 
Bootstrap 95% CI 43.9, 108.8, p<0.05.  After adjusting for age and IQ the HD group 
was also slower than controls at the difference between TMTA and B, mean 
difference 56.7 seconds, Bootstrap 95% CI 29.5, 87.4, p<0.05. 
Two out of 14 controls, and three out of eight HD participants failed the Peretz test, 
which was not statistically significant (p=0.31, Fisher’s exact test).  However the two 
controls who failed scored just below the cut-off, whilst the three HD participants 
who failed scored very poorly; after adjusting for age and IQ the mean difference 
between groups was statistically significant: mean difference 12.8 points, 95% CI 
3.4, 22.2, t(18)=-2.85, p=0.011. 
Mean performance for these tasks, with unadjusted and adjusted group differences, 
are presented in more detail in Appendix 7.  Further details of the regression models 
used are in Appendix 8. 
 
   
3.3 EMOTION RECOGNITION 
The mean proportions of correct responses for each target emotion are displayed in 
Figure 3.1.  Adjustment was made by using the parameters from the model to predict 
the expected value of the outcome variable when all potential confounding variables 
were set to their mean levels in the entire cohort.  Table 3-2 shows the odds ratios for 
a correct (intended) response for each emotion in each modality in the early HD 
group, relative to the odds of a correct (intended) response for the controls for each 
emotion in each modality, adjusted for age, estimated premorbid IQ, Benton score, 
Trail-Making B-A and gender.  Unadjusted odds ratios are reported in Appendix 7 
and further details of the regression model are in Appendix 8. 
3.3.1 Faces 
Early HD participants were significantly worse at recognising sad, angry and fearful 
faces relative to controls.  Note that because of the ceiling effect observed for happy 
faces, happy faces were not included in the model. 
3.3.2 Voices 
Early HD participants were significantly worse at recognising sad, angry and fearful 
voices relative to controls, but not happy voices. 
3.3.3 Music 
Early HD participants were significantly worse at recognising sad, angry and fearful 
music relative to controls, but not happy music. 
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Figure 3.1 Mean proportion correct for each group, emotion and modality, 
adjusted for age, IQ, Benton, Trail-Making B-A score and gender, with 95% 
CIs    
 86
   
Table 3-2 Odds of a correct response (95% confidence intervals) relative to 
controls for each emotion in each modality, after adjusting for age, estimated 
pre-morbid IQ, Benton facial recognition score, Trail-Making B-A, and gender 
 Intended emotion 
Faces Happy Sad Angry Fearful 
Controls a 1 1 1 
Early HD a 0.20 (0.07, 0.62)
p=0.005 
0.35 (0.20, 0.60) 
p<0.001 
0.09 (0.03, 0.26)
P<0.001 
 
 Intended emotion 
Voices Happy Sad Angry Fearful 
Controls 1 1 1 1 
Early HD 0.70 (0.37, 1.34) 
p=0.28 
0.50 (0.26, 0.98)
p=0.043 
0.45 (0.25, 0.81) 
p=0.007 
0.22 (0.11, 0.44)
p<0.001 
 
 Intended emotion 
Music Happy Sad Angry Fearful 
Controls 1 1 1 1 
Early HD 0.50 (0.21, 1.16) 
p=0.10 
0.46 (0.23, 0.93)
p=0.031 
0.48 (0.28, 0.82) 
p=0.007 
0.58 (0.36, 0.95)
p=0.028 
An odds ratio <1 means that the early HD group is less likely to recognise stimuli correctly than 
controls; where 95% confidence intervals are both <1 this means that the odds ratio is statistically 
significant at the p<0.05 level. 
a As controls were at ceiling on happy faces these data were excluded from the model, meaning there 
can be no comparison between groups for happy faces 
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3.3.4 Control performance 
The modal response in controls across modalities and emotions was almost always 
that of the target emotion, i.e. in general most controls correctly identified the target 
emotion.  Exceptions were one of the “angry” Ekman faces, which controls more 
often identified as “sad”, and one of the “fearful” musical excerpts, which controls 
more often identified as “angry”. 
Controls were at ceiling for happy faces, and on average scored highly (>8/10 
correct) for all other facial and vocal stimuli, across emotions.  Happy and sad 
musical stimuli were equally well-identified by this group, but their performance 
tended to be lower for angry and fearful musical stimuli, implying that these 
emotions in this modality were inherently harder to recognise. 
3.3.5 Within-group differences between emotions in each modality 
After taking control levels of performance into account, there was evidence that early 
HD participants found fearful face recognition harder than angry face recognition 
(OR 0.25, 95% CI 0.08, 0.78, p=0.017); there were no other statistically significant 
differences between emotion recognition performance in this modality.  In the vocal 
modality there was a tendency for HD participants to find fearful voices harder to 
recognise than angry voices (OR 0.49, 95% CI 0.24, 1.01, p=0.052).  In the music 
modality there were no statistically significant differences between recognition of 
sad, angry or fearful stimuli in the HD group. 
3.3.6 Within-group differences between modalities for each emotion 
After taking control performance into account there was no evidence that recognition 
of sad or angry stimuli in the HD group differed depending on modality.  On 
average, HD participants were worse at recognising fearful faces and fearful voices 
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than fearful music (fearful faces vs. music: OR 0.15, 95% CI 0.05, 0.44, p=0.001; 
fearful voices vs. music: OR 0.38, 95% CI 0.19, 0.74, p=0.004).  
3.3.7 Repeating analysis without participants who failed Peretz test 
It was not possible to include the Peretz score as a covariate in the main analysis as 
only a subset of participants completed the Peretz test and this would have left the 
analysis underpowered.  However the emotion recognition analysis was repeated 
without the five participants who failed the Peretz test (two controls, three early HD).  
Without these participants there was no longer evidence that the HD group found sad 
voices or sad music harder to recognise than controls.  Within the HD group there 
was now evidence that these participants found fearful voices harder to recognise 
than both sad and angry voices (fearful vs. sad voices: OR 0.32, 95% CI 0.12, 0.83, 
p=0.019; fearful vs. angry voices: OR 0.41, 95% CI 0.19, 0.89, p=0.024); in the main 
analysis there was merely a trend towards this effect in fearful vs. angry voices.  
Other findings were not materially changed. 
4 DISCUSSION 
4.1 MAIN FINDINGS 
This study demonstrates that early HD patients have difficulty recognising sad, angry 
and fearful stimuli in the facial, vocal and musical modalities.  Fearful stimuli tended 
to be harder for this group to recognise than sad or angry stimuli, in both the facial 
and vocal modalities.  There was also evidence that fear was harder for the HD group 
to recognise when presented using facial or vocal stimuli, compared with musical 
stimuli, although there was no evidence that recognition of other emotions differed 
materially between modalities.  These effects were found after taking into account 
age, estimated pre-morbid IQ, general facial recognition ability, an index of 
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executive skills and gender and so cannot be attributed to between-group differences 
in these abilities. 
This work adds to a large body of evidence showing that facial emotion recognition 
is impaired in early HD.  In common with a number of other studies, facial emotion 
recognition was impaired in the three negative emotions included in this paradigm.  
Many other studies have reported an impairment in facial fear and anger recognition 
(see e.g., Calder et al., 2010; Snowden et al., 2008 for recent examples).  An 
impairment in facial sadness recognition has been found in about two thirds of the 
studies in which it was tested although this seems more variable and may to some 
extent be modified by the stimulus set and response options available (Snowden et 
al., 2008). 
Far fewer studies have investigated vocal emotion recognition in HD, and in those 
that have, fear and anger recognition are often found to be impaired, but there have 
been no previous reports of an impairment in vocal sadness recognition (Calder et al., 
2010; Hayes et al., 2007; Snowden et al., 2008; Sprengelmeyer et al., 1996).  Even in 
the current study the impairment in vocal sadness recognition disappeared with the 
exclusion of the five participants who had done badly on the Montreal Battery of 
Evaluation of Amusia, which suggests that this effect was relatively weak, and may 
have been at least in part attributable to difficulties perceiving basic auditory 
qualities. 
Emotion recognition in music, a more abstract modality, has not previously been 
examined in HD.  Results mirrored those for the other two modalities, with 
impairments found in recognising angry and fearful music, and a suggestion that sad 
music recognition might be impaired although the latter effect was not found when 
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participants failing the Amusia Battery were excluded.  Overall, therefore, this early 
HD cohort demonstrates a cross-modal deficit in the recognition of angry and fearful 
stimuli. 
There has been much debate in the literature as to whether recognition of particular 
emotions is disproportionately impaired in HD.  Whilst some early studies argued in 
favour of a disproportionate impairment in disgust recognition (both facial and 
vocal), later and larger studies have tended to demonstrate either that anger is worst 
affected, or that the magnitude of the impairment does not differ significantly 
between negative emotions (compare e.g., Calder et al., 2010; Gray et al., 1997; 
Henley et al., 2008; Johnson et al., 2007; Sprengelmeyer et al., 1996).  In the current 
study participants tended to find fearful stimuli harder to recognise than angry or sad 
stimuli in the same modality.  However, as disgusting stimuli were not included in 
this study, and the response options were limited to four instead of the more usual 
six, this finding simply suggests that any disproportionate impairment is likely to 
depend on the experimental paradigm and adds weight to the view that recognition of 
most negative emotions is impaired, to some extent, in HD. 
Control performance in this study was relatively similar to that seen in other studies 
(e.g., Henley et al., 2008; Omar et al., 2011), with the group tending to perform well 
on most stimuli, but finding angry and fearful musical stimuli harder to recognise.  It 
was noted that, on average, the control group mis-identified two of the forty emotion 
stimuli, reporting an angry face as “sad” and a fearful musical clip as “angry”.  This 
is not an unusual finding bearing in mind that control participants were deliberately 
chosen to share social backgrounds with HD participants; two previous studies have 
found impairments in facial anger recognition in gene-negative controls relative to 
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“normal” healthy controls (Gray et al., 1997; Sprengelmeyer, Schroeder, Young, & 
Epplen, 2006).  As this is the first report of music emotion recognition in HD only 
future work will confirm whether mis-identification of fear in music is a chance 
finding or common in this group. 
Whilst some previous work has included facial and vocal stimuli in the same battery, 
inter-modality performance has not been compared statistically in any previous 
study.  In the current study recognition of fearful stimuli appeared to be easier for the 
HD group in the musical modality than in facial and vocal modalities.  However 
there was no evidence of inter-modality differences for sad or angry stimuli, 
suggesting that the level of impairment for these two emotions is broadly similar 
regardless of modality.   This has implications for the cognitive locus of impairment 
in HD; it seems likely that the impairment seen is at least partly attributable to an 
inability to access relatively high-level emotional conceptual or semantic knowledge, 
not just modality-specific instances of each emotion. 
This conclusion is consistent with previous research suggesting that recognition of 
emotion in music uses a similar network of brain regions as recognition of emotion 
in other stimuli (e.g. ventral striatum, amygdala, prefrontal cortex, insula (see 
Koelsch, 2010 for a review)).  Where components of this network are compromised 
we would predict cross-modal deficits, independent of the modality tested; modality-
specific deficits might be more dependent on difficulties with particular perceptual 
processes unique to each modality.  Indeed, other neurological populations have been 
shown to have impaired recognition of emotions across similar modalities, including 
those with Parkinson’s disease (van Tricht et al., 2010) and fronto-temporal lobar 
degeneration (FTLD) (Omar et al., 2011; Snowden et al., 2008).  In the former FTLD 
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population poor music emotion recognition performance was associated with reduced 
grey matter volume in a number of regions, including insular, anterior cingulate, 
orbitofrontal regions, hippocampus and amygdala, and the ventral striatum, all of 
which have been implicated in emotion processing in imaging studies of healthy 
participants, in facial, vocal and musical modalities (Adolphs, 2002).  There was also 
evidence of reduced grey matter in other regions, such as the medial pre-frontal 
cortex, which might be unique to music-specific processes and are also implicated in 
skills such as theory of mind.  It may be that the abstract nature of the musical 
stimulus requires participants to attribute a “mental state” to it, similar to what is 
required in theory of mind judgements, and that impairments in underlying brain 
structure impact on both sorts of task (Omar et al., 2011).  However it is unclear 
whether a similar skills deficit might underlie the music emotion recognition 
impairment seen in the current HD cohort, as recent evidence suggests that their 
social cognition difficulties may be qualitatively different to those seen in FTLD, and 
not be attributable to a fundamental theory of mind deficit (Snowden et al., 2003). 
4.2 LIMITATIONS 
A major limitation of the current study was the fact that the musical stimuli consisted 
of excerpts from existing Western classical music.  This made it impossible to 
control for familiarity or prior semantic association.  Although participants were 
asked to indicate whether they thought a clip was familiar, responses suggested that 
this was not a reliable index; for example participants sometimes claimed to 
recognise a clip from a particular piece, but said that they had never heard a later clip 
taken from the same piece (which seems unlikely).  Many clips will have been 
unfamiliar to many participants, forcing them to make a novel judgement about the 
emotion.  However some clips will have been familiar, and in particular may have 
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been associated with emotive events such as weddings, which could well have 
influenced response choice. This is most likely to have introduced noise into these 
data, and it is not clear to what extent this was the case, or whether there might have 
been a systematic bias for some more popular stimuli.  However, there is no evidence 
to suggest that familiarity would have differed systematically between control and 
HD participants, and hence it seems unlikely that it would have inflated group 
differences.  A potential solution to these concerns is to compose novel stimuli.  This 
has in fact been done, since the first set of data were collected for the current study, 
and a set of novel music emotion stimuli now exists (Hailstone et al., 2009). 
A related issue is that musical stimuli tend to induce higher physiological arousal 
than faces or voices (with neural correlates including amygdala and related systems) 
and therefore this is a potential confound when comparing behavioural (and imaging) 
data between musical and non-musical modalities (Omar et al., 2011).  Reduced 
arousal in neurological populations relative to controls may therefore inflate group 
differences in music emotion recognition scores.  In future studies it should be 
possible to use some measure of autonomic arousal in order to control or at least 
adjust for this. 
Participants reported a range of musical backgrounds (see Appendix 5), from those 
who rarely listened to music, to those who went about their daily lives with the radio 
on, and some who had had several years of formal musical training and still 
participated in amateur music-making.  Again, whilst there was no apparent bias 
towards either controls or HD participants being relatively more “musical”, it was 
not possible to quantify this in a meaningful way, and hence prior musical experience 
was not controlled for.  However, there is evidence that lack of musical training does 
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not prevent listeners from making accurate emotional categorisations from music 
(Peretz et al., 1998), and that music emotion recognition is consistent across listeners 
with a variety of musical backgrounds (Krumhansl, 1997) so it seems unlikely that 
varying musical backgrounds had a large influence on the results reported here.  
Nevertheless an effort to match groups for some measure of musical background 
would be needed in future work in order to minimise doubts about this.  
Finally, fewer than half the participants completed the Montreal Battery of 
Evaluation of Amusia (Peretz et al., 2003), meaning that it was not possible to adjust 
for this statistically in the main analysis.  Of those who completed it similar (small) 
proportions of control and early HD participants failed, but those HD participants 
who failed did very poorly, possibly suggesting a qualitative difference between 
them and the controls.  Reanalysing the data without these participants however did 
not change the major findings of impaired anger and fear recognition across 
modalities, but did suggest that the finding of impaired recognition of sad voices and 
music might have been attributable, at least in part, to aspects of musical perceptual 
ability, rather than emotion recognition skills per se.  In future it would be important 
to test all participants on some measure of musical perception in order to assess the 
influence of these skills on auditory emotion recognition generally.  There is 
increasing evidence that around 4% of the general population are “tone deaf”, i.e. 
born without the ability to discriminate tunes in music (congenital amusia) (Peretz, 
Cummings, & Dube, 2007; Stewart, 2008) and the Peretz battery is one way of 
testing for this. 
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4.3 FUTURE WORK 
Future work should initially focus on replicating the results reported here, as this is 
the first study to test music emotion recognition in HD, and to test statistically the 
differences between a number of modalities.  As mentioned above, it is important to 
control for factors such as age, education, executive function and gender as was done 
here, but also to attempt to minimise possible between-group differences due to 
musical ability and background.  Thus future studies would benefit from taking steps 
to do this, perhaps matching groups on some measure of “musicality”, and / or 
ensuring stringent testing for basic musical perceptual abilities.  In addition, the use 
of novel musical stimuli is recommended.  Regarding the facial and vocal stimuli, 
there is also some debate as to the ecological validity of the Ekman stimuli, which 
although very widely-used and therefore easily comparable, are static and black-and-
white, and therefore very unlike stimuli that would be encountered in everyday life.  
Some attempts to make moving facial stimuli have been made (Montagne et al., 
2006; Simon, Craig, Gosselin, Belin, & Rainville, 2007) which as well as seeming 
more ecologically-valid, would be a better match for auditory stimuli which are 
necessarily temporally dynamic.  Also, given that stimulus set can influence results 
within a single cohort (Snowden et al., 2008), it would seem important to conduct 
more studies in which more than one stimulus set is used in a given modality, in 
order to establish effects that are independent of this factor. 
Given the debate around the neural substrate underlying emotion perception in 
general, and music perception in particular, more structural and functional imaging 
studies of multi-modal emotion recognition should be encouraged.  In HD, as in 
FTLD, the pattern and progression of brain atrophy is relatively well characterised.  
Previous work in HD has used both voxel-based morphometry and functional 
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magnetic resonance imaging (fMRI) to examine neural correlates of facial emotion 
recognition in HD (Henley et al., 2008; Hennenlotter et al., 2004; Kipps et al., 2007) 
and this work could usefully be expanded to investigate which regions are implicated 
in emotion recognition across modalities in this population.  Unfortunately it was not 
possible to conduct an imaging study on the current cohort as not all participants had 
structural MRIs during their research visits, and those that did were performed on 
different scanners, with different field strengths, introducing several potential 
confounds. 
Comparatively few studies have looked at emotion recognition in presymptomatic 
HD (participants who carry the gene but are not yet judged to be showing 
unequivocal motor signs of the disease).  In part this may be because it is often hard 
to quantify how far from predicted disease onset these cohorts are, and cognitive 
deficits can be very subtle prior to motor onset, and therefore hard to detect using 
standard clinical tests.  Nevertheless with sensitive tests and adequate cohorts some 
changes can be detected many years prior to motor “onset” (Stout et al., 2011; 
Tabrizi et al., 2009) and it would be of interest to quantify the emotion recognition 
deficit better in this population, and to track how it changes over time.  To date very 
few studies in presymptomatic or symptomatic HD have looked in detail at emotion 
recognition longitudinally (an exception being Sprengelmeyer et al., 2006). 
Finally, there is very little published work examining the socio-emotional effects of 
this impairment on people with HD and their families and carers.  One recent study 
reports that impaired facial emotion recognition is associated with impaired everyday 
function (Ille et al., 2011), and these authors, along with many others, hypothesise 
that a breakdown in affect recognition could well underlie other social 
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communication problems seen in HD.  Others note that whilst people with HD 
recognise that their communication is slower and more effortful, their families and 
carers report that personality changes (such as difficulty changing perspective) affect 
communication negatively as the disease progresses (Hartelius, Jonsson, Rickeberg, 
& Laakso, 2010), and that interpersonal difficulties can be an early sign of the 
disease (Williams et al., 2007).  However, there does not seem to be an empirical 
study designed to assess whether deficits in emotion recognition have a direct impact 
on social communication, or to examine carers’ perspectives and experiences.  An 
ability to recognise and ascribe mental states (theory of mind) is a key skill needed 
for empathy, and many of the brain areas implicated in theory of mind and pro-social 
behaviour overlap with those thought to be affected in HD (Singer, 2006).  Therefore 
it would seem important that future studies address not only the nature of the deficits 
in HD, but the effect of this on those around people with HD.  Increased 
understanding of the causes of the social communication problems in the disease 
may help both patients and carers manage these difficulties more successfully, and 
thus go some way to mitigating their effects, even when the symptoms themselves 
cannot be alleviated. 
4.4 CONCLUSION 
The emotion recognition impairment in HD appears to be cross-modal, with 
recognition of angry and fearful stimuli in particular equally affected in the facial, 
vocal and musical domains.  This study does not support suggestions that particular 
emotions or modalities are disproportionately affected in early HD.  This suggests 
the involvement of relatively high-level neural systems, rather than modality-specific 
mechanisms.  In terms of the social impact of the disease, this means that 
unfortunately efforts to substitute information from one modality with that from 
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another are unlikely to mitigate the effects of impairment.  Further work should focus 
on using more ecologically-valid stimuli, and following up presymptomatic cohorts 
over time in order further to clarify the trajectory of the emotion recognition deficit 
in this population. 
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1 INTRODUCTION 
This appraisal reflects on three main aspects of conducting the research reported in 
Parts 1 and 2.  Firstly, there is a brief discussion of working on the systematic 
review, the pitfalls encountered and how these would be better managed in future.  
Secondly, it expands on the methodological limitations of the empirical work 
discussed briefly in Part 2.  Finally, I reflect more on the personal impact of working 
in a research setting with participants with a neurodegenerative disease. 
2 LITERATURE REVIEW 
The review of the literature covered a set of studies reporting quantitative results of 
emotion recognition performance in HD, a subject about which there is much debate.  
When planning the review, it was thought that a meta-analytic approach would be a 
sensible way to analyse such data.  A meta-analysis would potentially answer 
questions that have arisen about whether some emotions are disproportionately 
affected, and also allow consideration of the relationship between demographic 
variables and emotion recognition performance across cohorts.  The main difficulty 
with this approach was the unavailability of much of the necessary raw data.  
Quantitative outcomes were not reported in the published papers for several studies, 
and in addition many studies did not report the necessary demographic data such as 
IQ, CAG repeat length and UHDRS motor score.  Attempts were made to contact 
representatives of all the included studies.  However not all these attempts were 
successful, and even those that were sometimes resulted in data being promised, but 
not being sent before the review deadline, or in authors admitting that they had never 
had CAG repeat data and could not access their results a few years after the original 
study was performed.  On consideration it seemed that attempting a meta-analysis on 
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an incomplete data set would potentially raise as many questions as it answered, and 
subsequently the review was changed to be entirely narrative. 
If undertaking such a review again I would approach this problem differently.  
Firstly, with the experience of having done one such review, I would be quicker to 
identify what data I needed and what data were missing from the included studies.  I 
would then contact authors much earlier in the review process, and hence have more 
time to chase unanswered queries as the process moved on.  In general the responses 
I received were as helpful as they could be, and also many people expressed an 
interest in the work I was doing.  This was encouraging and also useful to have made 
links with other people in the field. 
3 EMPIRICAL STUDY 
3.1 RECRUITMENT 
Having had previous experience of research I was aware that recruitment was likely 
to take a long time, and that I would need to allocate a number of research days to 
making telephone calls, writing letters, and the administrative side of the project.  
With this in mind I submitted my ethics application as early as possible with a view 
to beginning to contact potential participants in the middle of 2010 and finishing data 
collection by the end of 2010.  This worked well and I was able to collect data on 20 
out of 25 of my extra participants within the planned timescale.  Unfortunately one of 
my last controls was unable to be visited because of unexpected bad weather, and 
then work commitments meant he had to withdraw from the study.  This left me 
trying to recruit one more participant in early January 2011, and ultimately meant 
data collection continued sporadically until early February.  On reflection, I should 
have anticipated more problems with recruiting from this population, as although 
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they tend to be very keen to be involved in research, there are a lot of projects 
running concurrently at the National Hospital which means that some participants are 
too busy to take on more.  However, overall because I had planned ahead with this 
aspect, data collection did not overrun by too much time. 
3.2 METHODOLOGICAL CHOICES 
In putting together the test battery there were a number of considerations.  It needed 
to be brief enough to administer in a single visit, well-tolerated, and the materials 
needed to be easily transportable as I was planning on testing people in their homes.  
The multimodal emotion test had already been developed and was the key test of 
interest, but background measures were needed for potential confounding variables 
such as estimated pre-morbid IQ, face recognition and musical skills, and executive 
function which is known to be affected in HD, and was thought might impact on 
emotion recognition performance.  Standard measures of IQ, face recognition and 
musical perception were included.   
3.2.1 Executive function 
There is a wide range of executive function tests and the Trail-Making Test was 
chosen partly because it is brief to administer and relatively free from floor and 
ceiling effects in the early HD population, and also because subtracting time A from 
time B yields an index of “task switching” with the motor component removed.  
With hindsight, I might consider using an alternative test such as phonemic fluency, 
as this is even simpler to administer and still an index of “frontal” lobe function. 
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3.2.2 Musical perception 
The Peretz battery was very long, and verged on being intolerable for some 
participants.  Participants must listen to 120 pairs of repeated tunes, and identify 
whether there is a one-note difference between each pair.  Most reported finding this 
hard, and losing concentration.  I tried to overcome this by encouraging them to stay 
focused, reminding them that they could request to hear stimuli again, and also 
breaking the test up (doing the first two sets of 30, and then having a short pause 
before completing the second two sets).  However the effects of reduced 
concentration and motivation cannot be ruled out on this test, and were I to use it in 
future studies I would investigate whether a briefer version could be developed and 
normed, or whether one or two subtests would provide sufficient data rather than 
four.  An addition problem in the current study is that not everyone completed the 
Peretz battery (as discussed in Part 2), meaning that it could not be included as a 
confounding variable in the main analysis.  Were I to conduct further follow-up 
studies I would certainly ensure that all participants had done some measure of music 
perception. 
3.2.3 Musical emotion recognition 
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The multimodal battery was developed using existing facial and non-verbal vocal 
stimuli, with the musical extracts added by me.  This was conceived as a pilot study, 
for which it was simpler to use existing classical music than to construct novel 
stimuli.  The extracts used were tested extensively prior to inclusion in the final 
battery, and the modal control response in the current study matched that of the target 
emotion for all stimuli except one. This suggests that despite variability, stimuli were 
generally consistently identified with the target emotion.  The one exception was a 
fearful stimulus which 10/25 controls identified as this, whilst 13/25 classed it as 
   
angry, and 2/25 as sad.  However, as reported in Parts 1 and 2, controls who are gene 
negative but related to someone carrying the HD gene are known to have slightly 
impaired emotion recognition skills relative to other healthy volunteers, so it is 
possible that this difference represented a characteristic of this control group, rather 
than a problem with the stimulus per se. 
One clear drawback of this approach is that people may have prior semantic links 
with certain clips of Western classical music, for example if they have heard them on 
television, or at a wedding.  Informally, participants were asked to indicate whether 
or not a clip was familiar, but this proved to be subjective and unreliable, with for 
example participants hearing two clips from the same piece of music and indicating 
that one was familiar whilst the other was not; or spontaneously mis-identifying a 
clip (e.g. labelling Mozart’s overture to The Marriage of Figaro as Beethoven’s Fifth 
Symphony, or stating “that’s not Jaws” on hearing the theme from Jaws).  Thus it 
was not possible to include familiarity judgements as a covariate, to see whether 
familiarity affected emotional attribution, as these judgements were clearly 
extremely unreliable and likely to simply add noise to the analysis. 
A more rigorous approach would obviously have been to compose novel stimuli, 
something which could not be done in the time available for this project.  However a 
set of novel musical stimuli have now been made (Hailstone et al., 2009) and the 
promising results of the current study suggest that further research with these novel 
stimuli may be of value. 
Another difficultly with this approach was that in order to be consistent between 
modalities, disgusting and surprising stimuli were omitted as it was considered 
impossible to render them musically.  In some ways this says something about the 
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nature of those two emotions, particularly disgust which, when portrayed facially or 
vocally tends to imply a visceral distaste for something physical; the more subtle 
meaning of moral disapproval does not seem to come across as well in typical 
examples of facial or vocal expressions (Calder et al., 2010).  Nevertheless, most 
other studies of emotion recognition in HD include these two emotions as stimuli and 
of course response options.  Different emotions are differentially confusable (disgust 
with anger, and fear with surprise, in particular) (Calder et al., 1996), which means 
that excluding some materially changes the nature of the test (and can lead to 
different conclusions using the same group of participants (Snowden et al., 2008)) 
and that is a potential weakness of this study. 
3.2.4 Participants 
The multidisciplinary HD clinic at the National Hospital in London is one of the 
largest clinics in the country, and there are very good links between clinical and 
research teams, meaning that there is a large body of potential participants.  Many 
people with HD prefer not to get involved in research, but there are also many who 
are keen to be involved in as much as possible.  There are currently several large, 
international longitudinal studies running at the National Hospital (e.g. Track-HD, 
Tabrizi et al., 2009), which, despite the willingness of patients to become involved in 
research, means that there is a risk that patients become over-tested, or that studies 
might begin to confound each other.  For example, it is unwise for cognitive testing 
to be repeated within a six-month period (and preferably longer) because of practice 
effects (see e.g., Bachoud-Lévi et al., 2001).  This means that when starting a 
relatively small, single-visit study such as this, there is a limit to potential recruits.  
Currently many of the working-age patients with HD are enrolled in Track-HD, 
which involves a whole day of testing annually, but may lead on to potential 
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treatment trials in the future.  Because of the timescale of testing for my study, I 
could only enrol participants from Track-HD if their Track-HD test dates were at 
least six months away from my test date.  In addition, because of the time 
commitment involved in Track-HD many participants could not commit themselves 
to further research studies.  What this tended to mean was that I had a 
disproportionate number of participants at either end of the age spectrum; some who 
were too young for Track-HD, and some who were past retirement age and therefore 
freer to attend a number of research visits.  With more time, and perhaps support 
from other researchers, I would have been able to balance this, but within the 
timescale available to me this was not possible. 
3.2.5 Including imaging data 
Given the debate in the literature about emotion recognition in HD and other 
domains, it would have been a useful addition to have included some structural 
imaging in the study.  The original 25 participants had structural MRI scans as part 
of the London Longitudinal study.  When originally planning the extension it was 
thought that if I could recruit the extra 25 participants from existing imaging studies I 
could use their structural MRIs (with permission).  Whilst every participant 
consented to this, unfortunately it was not possible to recruit all 25 from existing 
imaging studies, and that meant that several participants did not have imaging 
available.  In addition there would have been two other potentially large confounds: 
the original 25 were scanned on a 1.5T scanner, whilst later participants were 
scanned on a 3T scanner; and the original 25 had scans on the same day as cognitive 
testing, whereas the later participants who had imaging had often had it several 
months before I saw them.  Time and importantly financial constraints meant that it 
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was not possible to include a structural MRI scan in the protocol for this study, and 
therefore the imaging part could not be completed. 
3.3 WORKING WITH PEOPLE WITH A NEURODEGENERATIVE DISEASE 
I have worked with people with HD since 2003, and therefore came to this study 
with a good idea of what was involved, particularly emotionally, in meeting people 
whose lives are being devastated by the disease.  Even so, there were times when it 
was particularly hard to manage my feelings, at the same time as maintaining a 
professional outlook and balancing the needs of the study with the needs of the 
participants. 
Some of the participants whom I tested in the last 12 months were people whom I 
had first met seven years ago.  In some cases their disease seemed very little 
advanced, and it was encouraging to see them and hear how they had managed.  In 
other cases people had very obviously deteriorated, as could be seen by their motor 
symptoms and also in their accounts, and their partners’ accounts, of difficulties with 
everyday tasks (such as managing finances) and personal relationships.  It was very 
sad to experience this, and it was hard, and sometimes impossible, to “switch off” at 
the end of a testing session and not reflect on the changes I had noticed. 
There were also situations with participants whom I hadn’t met before which were 
challenging.  One family had only recently had HD diagnosed in an elderly 
participant, and were still adjusting to the realisation that either or both of their 
children might be affected, and their children’s children, and how to manage this.  
Mine was the first research study they had done, and understandably they were full 
of hope that research might provide a cure for the next generation, but also full of 
questions.  I had to try to be honest in my answers, acknowledging the limits of my 
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knowledge even when there was pressure just to reassure, and also acknowledging 
the limits of my role – as researcher, not clinician. 
Another participant was one of the youngest, yet had relatively advanced disease.  
This participant had two young children, and the non-gene-carrying partner spoke 
briefly of the struggles to cope with family life, and with the affected partner’s 
nearby family, who were finding it hard to come to terms with the diagnosis.  I had 
visited them at home, so could see for myself the difficulties they were both facing, 
and I could imagine the challenges that would present as the disease got worse.  
Again, it was very difficult to focus on research in the face of this, and to ensure that 
I spent some time hearing what the participants wanted to say to me, and reflecting 
their concerns, as well as helping them complete the cognitive tests. 
It was also not just participants with HD who presented challenges such as this.  One 
young control was married to an at-risk person, and this was the first research study 
she had enrolled in.  She broke down at the beginning of testing, talking about the 
difficulties of living with uncertainty, and was so distressed that I spent some time 
completing a risk assessment with her, and making sure she was aware of external 
support systems that she could access if needed.  Ultimately she opted to complete 
the testing, because she felt that this was the only way she could gain some control 
over the disease, and “give something back”, which is a common feeling amongst 
most of the people I tested. 
It was while conducting research with this population before that I became frustrated 
with my inability to offer them any clinical help, and decided to apply for clinical 
training.  In a way it was frustrating to find myself back in that position, being 
careful not to blur the line between researcher and clinician.  However that was 
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balanced by the fact that I do have many more clinical skills now than a few years 
ago, which meant that even within the research setting I felt more confident about 
taking some time just to listen, reflect back dilemmas to participants, assess risk, and 
discuss whether they would like to be put in touch with other agencies that could 
offer more clinical help.  I also had both my supervisors to report to, as well as the 
support network of the HD clinical and research teams at the National Hospital, and 
lay agencies such as the UK Huntington’s Disease Association (www.hda.org.uk). 
Overall, the emotional impact of working with this population was challenging, and 
sometimes led me to question the “usefulness” of what I was doing, particularly 
when contrasted with my day-to-day clinical work in which I could more obviously 
apply my skills to helping people with mental distress.  However, all the participants 
knew, as I did, that this study was not about changing their quality of life, but simply 
about shedding more light on the nature of the disease.  They were still willing to 
participate, and nearly all expressed their belief that by doing so they were helping, 
and fighting back.  That attitude in itself is one of the reasons why it is also 
extremely rewarding, and inspirational to work with this population. 
4 SUMMARY 
Overall, whilst this study has methodological limitations as outlined above, I think it 
was successful in terms of piloting a new concept (music emotion recognition) with 
the HD population.  Reflecting on the limitations has been useful in clarifying what 
changes should be made in future studies, and given that this is the first time music 
emotion stimuli have been used in HD, it would be wise to try to replicate and 
expand on the findings presented here. 
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Working with people with HD and their families also presents personal challenges 
from both a clinical and research point of view.  However, their willingness to get 
involved, and their hope for the future, mean that it is also a rewarding and 
motivating experience. 
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degenerative cerebellar diseases. [Spanish]. Revista Neurologica Argentina, 32, 20-34. 
Includes social cognition tests but they are Theory 
of Mind and gambling, not emotion recognition. 
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subcortical diseases: do true neuropsychological differences exist? Arch.Clin.Neuropsychol., 21, 29-40. 
No emotion recognition tasks in battery. 
Bachoud-Levi, A. C., Maison, P., Bartolomeo, P., Boisse, M. F., Dalla, B. G., Ergis, A. M. et al. (2001). Retest effects 
and cognitive decline in longitudinal follow-up of patients with early HD. Neurology, 56, 1052-1058. 
No emotion recognition tasks in battery. 
Baker, J. G. (1996). Memory and emotion processing in cortical and subcortical dementia. J.Gen.Psychol., 123, 185-
191. 
Summary of old research, nothing novel. 
Bales, K. R. (2004). Neurodegenerative disease research in the 21st century. Drug Discovery Today, 9, 553-556. Conference review. 
Bamford, K. A., Caine, E. D., Kido, D. K., Cox, C., & Shoulson, I. (1995). A prospective evaluation of cognitive 
decline in early Huntington's disease: functional and radiographic correlates. Neurology, 45, 1867-1873. 
No emotion recognition tasks in battery. 
Barquero-Jimenez, M. S. & Gomez-Tortosa, E. (2001). [Cognitive disorders in patients with Huntington's disease]. 
Rev.Neurol., 32, 1067-1071. 
No emotion recognition tasks in battery. 
Baudic, S., Maison, P., Dolbeau, G., Boisse, M. F., Bartolomeo, P., Dalla, B. G. et al. (2006). Cognitive impairment 
related to apathy in early Huntington's disease. Dement.Geriatr.Cogn Disord., 21, 316-321. 
No emotion recognition tasks in battery. 
Berrios, G. E., Wagle, A. C., Markova, I. S., Wagle, S. A., Rosser, A., & Hodges, J. R. (2002). Psychiatric symptoms in 
neurologically asymptomatic Huntington's disease gene carriers: a comparison with gene negative at risk subjects. Acta 
Psychiatr.Scand., 105, 224-230. 
No emotion recognition tasks in battery. 
Blackmore, L., Simpson, S. A., & Crawford, J. R. (1995). Cognitive performance in UK sample of presymptomatic 
people carrying the gene for Huntington's disease. J.Med.Genet., 32, 358-362. 
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Bodner, T., Jenner, C., Benke, T., Ober, A., Seppi, K., & Fleischhacker, W. W. (2001). Intoxication with riluzole in 
Huntington's disease. Neurology, 57, 1141-1143. 
Case report. 
Bonelli, R. M. & Kapfhammer, H. P. (2003). Why minocycline is helpful in Huntington's disease. J.Psychopharmacol., 
17, 461. 
Drug report. 
Boxer, A. L. & Yoon, G. (2007). Reply from the authors [6]. Neurology, 68, 1325. Reply to query about juvenile HD. 
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deficits in Huntington's disease gene carriers and correlates of early "conversion". J.Neuropsychiatry Clin.Neurosci., 20, 
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degeneration: a comparison with Huntington's disease. J.Neuropsychiatry Clin.Neurosci., 16, 176-184. 
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Brandt, J., Shpritz, B., Codori, A. M., Margolis, R., & Rosenblatt, A. (2002). Neuropsychological manifestations of the 
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Campodonico, J. R., Codori, A. M., & Brandt, J. (1996). Neuropsychological stability over two years in asymptomatic 
carriers of the Huntington's disease mutation. J.Neurol.Neurosurg.Psychiatry, 61, 621-624. 
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de Boo, G. M., Tibben, A., Lanser, J. B., Jennekens-Schinkel, A., Hermans, J., Maat-Kievit, A. et al. (1997). Early 
cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch.Neurol., 54, 1353-1357. 
No emotion recognition tasks in battery. 
de Gelder, B., Van den Stock, J., Balaguer, R. D., & Bachoud-Levi, A. C. (2008). Huntington's disease impairs 
recognition of angry and instrumental body language. Neuropsychologia, 46, 369-373. 
Emotion matching (within modality), not explicit 
emotion recogntion, labelling or cross-modality 
matching. 
Derouesne, C. (2004). [Cognitive disorders at the onset of Huntington disease]. Psychol.Neuropsychiatr.Vieil., 2, 226-
227. 
Editorial, no novel data. 
Duff, K., Beglinger, L. J., Theriault, D., Allison, J., & Paulsen, J. S. (2010). Cognitive deficits in Huntington's disease 
on the Repeatable Battery for the Assessment of Neuropsychological Status. J.Clin.Exp.Neuropsychol., 32, 231-238. 
No emotion recognition tasks in battery. 
Fletcher, L. (1997). Computer 'games' diagnose early Huntington's disease. Mol.Med.Today, 3, 48-49. Focuses on CANTAB as diagnostic tool for HD, 
not emotion recognition. 
Giordani, B., Berent, S., Boivin, M. J., Penney, J. B., Lehtinen, S., Markel, D. S. et al. (1995). Longitudinal 
neuropsychological and genetic linkage analysis of persons at risk for Huntington's disease. Arch.Neurol., 52, 59-64. 
No emotion recognition tasks in battery. 
Gomez-Anson, B., Alegret, M., Munoz, E., Monte, G. C., Alayrach, E., Sanchez, A. et al. (2009). Prefrontal cortex 
volume reduction on MRI in preclinical Huntington's disease relates to visuomotor performance and CAG number. 
Parkinsonism Relat Disord., 15, 213-219. 
No emotion recognition tasks in battery. 
Gomez-Anson, B., Alegret, M., Munoz, E., Sainz, A., Monte, G. C., & Tolosa, E. (2007). Decreased frontal choline and 
neuropsychological performance in preclinical Huntington disease. Neurology, 68, 906-910. 
No emotion recognition tasks in battery. 
Gomez-Tortosa, E., del, B. A., Garcia Ruiz, P. J., Pernaute, R. S., Benitez, J., Barroso, A. et al. (1998). Severity of 
cognitive impairment in juvenile and late-onset Huntington disease. Arch.Neurol., 55, 835-843. 
No emotion recognition tasks in battery. 
Hahn-Barma, V., Deweer, B., Durr, A., Dode, C., Feingold, J., Pillon, B. et al. (1998). Are cognitive changes the first 
symptoms of Huntington's disease? A study of gene carriers. J.Neurol.Neurosurg.Psychiatry, 64, 172-177. 
No emotion recognition tasks in battery. 
Halligan, P. W. (1998). Inability to recognise disgust in Huntington's disease. Lancet, 351, 464. Commentary, no novel data. 
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Reference Reason for exclusion 
Hoth, K. F., Paulsen, J. S., Moser, D. J., Tranel, D., Clark, L. A., & Bechara, A. (2007). Patients with Huntington's 
disease have impaired awareness of cognitive, emotional, and functional abilities. J.Clin.Exp.Neuropsychol., 29, 365-
376. 
No emotion recognition tasks in battery. 
Jacobs, D. H., Shuren, J., & Heilman, K. M. (1995). Impaired perception of facial identity and facial affect in 
Huntington's disease. Neurology, 45, 1217-1218. 
Includes emotion testing but tests matching and 
discriminating, not labelling / explicit recognition; 
also no controls. 
Jason, G. W., Suchowersky, O., Pajurkova, E. M., Graham, L., Klimek, M. L., Garber, A. T. et al. (1997). Cognitive 
manifestations of Huntington disease in relation to genetic structure and clinical onset. Arch.Neurol., 54, 1081-1088. 
No emotion recognition tasks in battery. 
Jurgens, C. K., van de, W. L., van Es, A. C., Grimbergen, Y. M., Witjes-Ane, M. N., Van Der, G. J. et al. (2008). Basal 
ganglia volume and clinical correlates in 'preclinical' Huntington's disease. J.Neurol., 255, 1785-1791. 
No emotion recognition tasks in battery. 
Lawrence, A. D., Hodges, J. R., Rosser, A. E., Kershaw, A., Ffrench-Constant, C., Rubinsztein, D. C. et al. (1998a). 
Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain, 121, 1329-1341. 
No emotion recognition tasks in battery. 
Lawrence, A. D., Watkins, L. H., Sahakian, B. J., Hodges, J. R., & Robbins, T. W. (2000). Visual object and 
visuospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain, 
123, 1349-1364. 
No emotion recognition tasks in battery. 
Lawrence, A. D., Weeks, R. A., Brooks, D. J., Andrews, T. C., Watkins, L. H., Harding, A. E. et al. (1998b). The 
relationship between striatal dopamine receptor binding and cognitive performance in Huntington's disease. Brain, 121, 
1343-1355. 
No emotion recognition tasks in battery. 
Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2002). Longitudinal study 
evaluating neuropsychological changes in so-called asymptomatic carriers of the Huntington's disease mutation after 1 
year. Acta Neurol.Scand., 106, 131-141. 
No emotion recognition tasks in battery. 
Lemiere, J., Decruyenaere, M., Evers-Kiebooms, G., Vandenbussche, E., & Dom, R. (2004). Cognitive changes in 
patients with Huntington's disease (HD) and asymptomatic carriers of the HD mutation--a longitudinal follow-up study. 
J.Neurol., 251, 935-942. 
No emotion recognition tasks in battery. 
Lichter, D. G. & Hershey, L. A. (2010). Before chorea. Pre-Huntington mild cognitive impairment. Neurology.75, 490-
491. 
Commentary, no novel data. 
Morris, M. (1995). Dementia and cognitive changes in Huntington's disease. Adv.Neurol., 65, 187-200. Review, no data. 
Nehl, C. & Paulsen, J. S. (2004). Cognitive and psychiatric aspects of Huntington disease contribute to functional 
capacity. J.Nerv.Ment.Dis., 192, 72-74. 
No emotion recognition tasks in battery. 
Paulsen, J. S. & Conybeare, R. A. (2005). Cognitive changes in Huntington's disease. Adv.Neurol., 96, 209-225. Review, no data. 
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Reference Reason for exclusion 
Paulsen, J. S., Hayden, M., Stout, J. C., Langbehn, D. R., Aylward, E., Ross, C. A. et al. (2006). Preparing for 
preventive clinical trials: the Predict-HD study. Arch.Neurol., 63, 883-890. 
Same data are presented (but with slightly more 
participants) in the Johnson et al. 2007 paper 
which is included in review (Julie Stout, personal 
communication) 
Paulsen, J. S., Langbehn, D. R., Stout, J. C., Aylward, E., Ross, C. A., Nance, M. et al. (2008). Detection of 
Huntington's disease decades before diagnosis: the Predict-HD study. J.Neurol.Neurosurg.Psychiatry, 79, 874-880. 
No emotion recognition tasks in battery. 
Paulsen, J. S., Wang, C., Duff, K., Barker, R., Nance, M., Beglinger, L. et al. (2010). Challenges assessing clinical 
endpoints in early Huntington disease. Mov Disord., 25, 2595-2603 
No emotion recognition tasks in battery. 
Pierrot-Deseilligny, C. (2001). Actualites American Academy of Neurology Philadelphie, 5-11 mai 2001* compte-
rendu du congres. [French]. Revue Neurologique, 157, 578-600. 
Congress account, no data. 
Pillon, B., Dubois, B., & Agid, Y. (1996). Testing cognition may contribute to the diagnosis of movement disorders. 
Neurology, 46, 329-334. 
Review, no data. 
Redondo, V. L., Brown, R. G., & Chacon, J. (2001). [Executive dysfunction in Huntington's disease]. Rev.Neurol., 32, 
923-929. 
No emotion recognition tasks in battery. 
Robins Wahlin, T. B., Lundin, A., & Dear, K. (2007). Early cognitive deficits in Swedish gene carriers of Huntington's 
disease. Neuropsychology, 21, 31-44. 
No emotion recognition tasks in battery. 
Rodrigues, G. R., Souza, C. P., Cetlin, R. S., de Oliveira, D. S., Pena-Pereira, M., Ujikawa, L. T. et al. (2009). Use of 
the frontal assessment battery in evaluating executive dysfunction in patients with Huntington's disease. J.Neurol., 256, 
1809-1815. 
No emotion recognition tasks in battery. 
Roger, K. S. (2005). Exploring memory loss: A study starts. Journal of Dementia Care, 13, 36. Commentary. 
Rogers, D. (1993). Movement disorders. Current Opinion in Psychiatry, 6, 113-116. Review, no data. 
Roitberg, B. (2004). Research news and notes. Surgical Neurology, 61, 106-108. Commentary. 
Rosas, H. D., Salat, D. H., Lee, S. Y., Zaleta, A. K., Pappu, V., Fischl, B. et al. (2008). Cerebral cortex and the clinical 
expression of Huntington's disease: complexity and heterogeneity. Brain., 131, 1057-1068. 
No emotion recognition tasks in battery. 
Rosas, H. D., Tuch, D. S., Hevelone, N. D., Zaleta, A. K., Vangel, M., Hersch, S. M. et al. (2006). Diffusion tensor 
imaging in presymptomatic and early Huntington's disease: Selective white matter pathology and its relationship to 
clinical measures. Mov Disord., 21, 1317-1325. 
No emotion recognition tasks in battery. 
Rosenberg, N. K., Sorensen, S. A., & Christensen, A. L. (1995). Neuropsychological characteristics of Huntington's 
disease carriers: a double blind study. J.Med.Genet., 32, 600-604. 
No emotion recognition tasks in battery. 
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Reference Reason for exclusion 
Rupp, J., Blekher, T., Jackson, J., Beristain, X., Marshall, J., Hui, S. et al. (2010). Progression in prediagnostic 
Huntington disease. J.Neurol.Neurosurg.Psychiatry, 81, 379-384. 
No emotion recognition tasks in battery. 
Sawa, A. & Snyder, S. H. (2005). Two genes link two distinct psychoses. Science, 310, 1128-1129. Genes for psychosis. 
Sax, D. S., Powsner, R., Kim, A., Tilak, S., Bhatia, R., Cupples, L. A. et al. (1996). Evidence of cortical metabolic 
dysfunction in early Huntington's disease by single-photon-emission computed tomography. Mov Disord., 11, 671-677. 
No emotion recognition tasks in battery. 
Simpson, S. A. (2004). The management of Huntington's disease. Practical Neurology, 4, 204-211. Review, no data. 
Snowden, J. S., Craufurd, D., Thompson, J., & Neary, D. (2002). Psychomotor, executive, and memory function in 
preclinical Huntington's disease. J.Clin.Exp.Neuropsychol., 24, 133-145. 
No emotion recognition tasks in battery. 
Soliveri, P., Monza, D., Piacentini, S., Paridi, D., Nespolo, C., Gellera, C. et al. (2002). Cognitive and psychiatric 
characterization of patients with Huntington's disease and their at-risk relatives. Neurol.Sci., 23 Suppl 2, S105-S106. 
No emotion recognition tasks in battery. 
Solomon, A. C., Stout, J. C., Weaver, M., Queller, S., Tomusk, A., Whitlock, K. B. et al. (2008). Ten-year rate of 
longitudinal change in neurocognitive and motor function in prediagnosis Huntington disease. Mov Disord., 23, 1830-
1836. 
No emotion recognition tasks in battery. 
Sprengelmeyer, R., Young, A. W., Sprenglemeyer, A., Calder, A. J., Rowland, D., Perrett, D. et al. (1997). Recognition 
of facial expressions: Selective impairment of specific emotions in Huntington's disease. Cognitive Neuropsychology, 
Vol.14, 839-879. 
Two case studies. 
Sprengelmeyer, R. (2007). The neurology of disgust. Brain, 130, 1715-1717. Commentary. 
Stout, J. C., Weaver, M., Solomon, A. C., Queller, S., Hui, S., Johnson, S. A. et al. (2007). Are cognitive changes 
progressive in prediagnostic HD? Cogn Behav.Neurol., 20, 212-218. 
No emotion recognition tasks in battery. 
Thieben, M. J., Duggins, A. J., Good, C. D., Gomes, L., Mahant, N., Richards, F. et al. (2002). The distribution of 
structural neuropathology in pre-clinical Huntington's disease. Brain., 125, 1815-1828. 
No emotion recognition tasks in battery. 
Thompson, J. C., Poliakoff, E., Sollom, A. C., Howard, E., Craufurd, D., & Snowden, J. S. (2010). Automaticity and 
attention in Huntington's disease: when two hands are not better than one. Neuropsychologia, 48, 171-178. 
No emotion recognition tasks in battery. 
Thompson, J. C., Snowden, J. S., Craufurd, D., & Neary, D. (2002). Behavior in Huntington's disease: dissociating 
cognition-based and mood-based changes. J.Neuropsychiatry Clin.Neurosci., 14, 37-43. 
No emotion recognition tasks in battery. 
Timman, R., Tibben, A., & Roos, R. A. (2003). Nonlinear effects in behavioral changes in Huntington disease. Cogn 
Behav.Neurol., 16, 82. 
Letter, no novel data. 
Tost, H., Wendt, C. S., Schmitt, A., Heinz, A., & Braus, D. F. (2004). Huntington's disease: phenomenological diversity 
of a neuropsychiatric condition that challenges traditional concepts in neurology and psychiatry. Am.J.Psychiatry, 161, 
28-34. 
Case study. 
van Oostrom, J. C., Dekker, M., Willemsen, A. T., de Jong, B. M., Roos, R. A., & Leenders, K. L. (2009). Changes in 
striatal dopamine D2 receptor binding in pre-clinical Huntington's disease. Eur.J.Neurol., 16, 226-231. 
No emotion recognition tasks in battery. 
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Reference Reason for exclusion 
van Walsem, M. R., Sundet, K., Retterstol, L., & Sundseth, O. (2010). A double blind evaluation of cognitive decline in 
a Norwegian cohort of asymptomatic carriers of Huntington's disease. J.Clin.Exp.Neuropsychol., 32, 590-598. 
No emotion recognition tasks in battery. 
Verny, C., Allain, P., Prudean, A., Malinge, M. C., Gohier, B., Scherer, C. et al. (2007). Cognitive changes in 
asymptomatic carriers of the Huntington disease mutation gene. Eur.J.Neurol., 14, 1344-1350. 
No emotion recognition tasks in battery. 
Veyssier-Belot, C. (2005). Psychiatric disorders and systemic diseases. [French]. Revue de Medecine Interne, 26, 682-
685. 
Review, no novel data. 
Videnovic, A., Bernard, B., Fan, W., Jaglin, J., Leurgans, S., & Shannon, K. M. (2010). The Montreal Cognitive 
Assessment as a screening tool for cognitive dysfunction in Huntington's disease. Mov Disord., 25, 401-404. 
No emotion recognition tasks in battery. 
Wang, K., Hoosain, R., Yang, R. M., Meng, Y., & Wang, C. Q. (2003). Impairment of recognition of disgust in Chinese 
with Huntington's or Wilson's disease. Neuropsychologia, 41, 527-537. 
Genetic confirmation not available (Wang, 
personal communication). 
Ward, J., Sheppard, J. M., Shpritz, B., Margolis, R. L., Rosenblatt, A., & Brandt, J. (2006). A four-year prospective 
study of cognitive functioning in Huntington's disease. J.Int.Neuropsychol.Soc., 12, 445-454. 
No emotion recognition tasks in battery. 
Wetter, S., Peavy, G., Jacobson, M., Hamilton, J., Salmon, D., & Murphy, C. (2005). Olfactory and auditory event-
related potentials in Huntington's disease. Neuropsychology, 19, 428-436. 
Investigates odour perception but not emotion or 
disgust. 
Wetter, S. R. (2003). Olfactory psychophysics and electrophysiology in huntington's disease. Thesis - based on same concepts as Wetter et al. 
(2005), above. 
Wexler, A. (2006). Huntington disease [2]. Journal of the Royal Society of Medicine, 99, 53. Letter, no novel data. 
Wild, E. J. & Tabrizi, S. J. (2006). Predict-HD and the future of therapeutic trials. Lancet Neurology, 5, 724-725. Commentary. 
Wilkinson, D. & Halligan, P. (2004). The relevance of behavioural measures for functional-imaging studies of 
cognition. Nat.Rev.Neurosci., 5, 67-73. 
Commentary. 
Williams, R. (2006). Hunting for huntingtin modification. Nature Reviews Neuroscience, 7, 503. Research highlights, no novel data. 
Witjes-Ane, M. N., Mertens, B., van Vugt, J. P., Bachoud-Levi, A. C., van Ommen, G. J., & Roos, R. A. (2007). 
Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. J.Neuropsychiatry Clin.Neurosci., 19, 
310-317. 
No emotion recognition tasks in battery. 
Witjes-Ane, M. N., Vegter-Van, D., V, van Vugt, J. P., Lanser, J. B., Hermans, J., Zwinderman, A. H. et al. (2003). 
Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. J.Neuropsychiatry 
Clin.Neurosci., 15, 7-16. 
No emotion recognition tasks in battery. 
Young, A. W., Sprengelmeyer, R., Phillips, M., & Calder, A. J. (1997). Response from Young, Sprengelmeyer, Phillips 
and Calder. [References]. Trends in Cognitive Sciences, Vol.1, 322-325. 
Response to comments about original 
Sprengelmeyer paper, no novel data. 
Zakzanis, K. K. (1998). The subcortical dementia of Huntington's disease. J.Clin.Exp.Neuropsychol., 20, 565-578. Review, no novel data. 
Zihl, J. (2004). Clear indications of emotion depend on vivid stimuli. Journal of Neurology, Neurosurgery and 
Psychiatry,75, 1658-1659. 
Comment on emotion recognition testing. 
   
APPENDIX 2: INDIVIDUAL STUDIES (FROM INCLUDED REFERENCES) THAT DID NOT MEET SEARCH CRITERIA FOR 
LITERATURE REVIEW 
Study and reference Reason for exclusion 
Aviezer et al. (2009): Experiment 2 Participants were asked to identify facial emotion expressions that were superimposed on body images portraying a different 
emotion and thus the experiment was not assessing “pure” emotion recognition in either modality. 
Calder et al. (2010): Study 2 Participants were asked to match photographs of different “types” of disgust recognition with a written scenario, i.e. was too 
specific for this review. 
Hayes et al. (2007): Experiments 1, 3, 4, 5, 6, 
7 
These experiments did not include an overt recognition component.  Expt. 1 required participants to describe situations that 
would induce emotions, in Expt. 3 participants had to categorise emotional words, in Expt. 4 they had to categorise emotion-
inducing scenes, all of which might rely solely or in part on semantic knowledge.  In Expt. 5 their experience of disgust was 
assessed using a questionnaire, and in Expts. 6 and 7 they were asked to rate odours and tastes but this did not include the 
explicit label “disgust”. 
Milders et al. (2003): Test 2 Test 2 involved matching facial expressions and therefore did not meet criteria for explicit emotion recognition. 
Snowden et al. (2008):  Tasks 1, 2, 3, 6, 7 Task 1 required participants to define emotion labels, Task 2 asked participants to pick synonyms or link emotion words with 
specific scenarios, and Task 3 repeated Task 2 but with reduced response options; thus these tasks were not examining 
explicition recognition of emotional stimuli.  Task 6 was a facial expression matching task, and Task 7 assessed facial 
identity matching. 
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 ETHICAL APPROVAL LETTER 
The National Hospital for Neurology and Neurosurgery 
& Institute of Neurology Joint REC 
 
 
 
 
 
Our Ref 010L 135 
REC Office
South House
Royal Free Hospital
Pond Street
London
NW3 2QG
Tel:  020 7794 0500 ext. 31342
Fax: 0207 7941004
Email: 
Sasha.Vandayar@royalfree.nhs.uk
Website:  www.uclh.nhs.uk
25 March 2010 
 
Dear Dr Henley 
 
Study Title: Multimodal emotion recognition in Huntington's 
Disease 
REC reference number: 10/H0716/9 
Protocol number: 2 
 
Thank you for your letter of 08 March 2010, responding to the Committee’s request 
for further information on the above research and submitting revised documentation. 
 
The further information was considered by a sub-committee of the REC at a meeting 
held on 24/03/2010 A list of the sub-committee members is attached.   
 
Confirmation of ethical opinion 
On behalf of the Committee, I am pleased to confirm a favourable ethical opinion for 
the above research on the basis described in the application form, protocol and 
supporting documentation as revised, subject to the conditions specified below. 
 
Ethical review of research sites 
The favourable opinion applies to all NHS sites taking part in the study, subject to 
management permission being obtained from the NHS/HSC R&D office prior to the 
start of the study (see “Conditions of the favourable opinion” below). 
 
Conditions of the favourable opinion 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
 
Management permission or approval must be obtained from each host organisation 
prior to the start of the study at the site concerned. 
 
For NHS research sites only, management permission for research (“R&D 
approval”) should be obtained from the relevant care organisation(s) in accordance 
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 with NHS research governance arrangements.  Guidance on applying for NHS 
permission for research is available in the Integrated Research Application System 
or at http://www.rdforum.nhs.uk.  Where the only involvement of the NHS 
organisation is as a Participant Identification Centre, management permission for 
research is not required but the R&D office should be notified of the study. Guidance 
should be sought from the R&D office where necessary. 
 
Sponsors are not required to notify the Committee of approvals from host 
organisations. 
It is the responsibility of the sponsor to ensure that all the conditions are 
complied with before the start of the study or its initiation at a particular site 
(as applicable). 
 
Approved documents 
The final list of documents reviewed and approved by the Committee is as follows: 
  
Document    Version  Date    
Covering Letter  1  06 January 2010  
REC application  2.5  08 January 2010  
Protocol  2  14 February 2009  
Letter of invitation to participant  1  14 December 2009  
Referees or other scientific critique report  1  23 October 2009  
Questionnaire: Hailstone Music Questionnaire 1  15 September 2009  
GP/Consultant Information Sheets  1  14 December 2009  
Response to Request for Further Information    08 March 2010  
Participant Information Sheet: Controls  4  25 February 2010  
Participant Information Sheet: Patients  4  25 February 2010  
Participant Consent Form: Controls  3  25 February 2010  
Participant Consent Form: Patients  3  25 February 2010  
 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements for 
Research Ethics Committees (July 2001) and complies fully with the Standard 
Operating Procedures for Research Ethics Committees in the UK. 
 
After ethical review 
Now that you have completed the application process please visit the National 
Research Ethics Service website > After Review 
 
You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure.  If you wish to 
make your views known please use the feedback form available on the website. 
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The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
 
  
• Notifying substantial amendments 
• Adding new sites and investigators 
• Progress and safety reports 
• Notifying the end of the study 
 
The NRES website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures. 
 
We would also like to inform you that we consult regularly with stakeholders to 
improve our service. If you would like to join our Reference Group please email 
referencegroup@nres.npsa.nhs.uk.  
 
 
10/H0716/9 Please quote this number on all 
correspondence 
 
Yours sincerely 
 
 
 
 
Dr Yogi Amin 
Chair 
 
Email: sasha.vandayar@royalfree.nhs.uk 
 
Enclosures: List of names and professions of members who were present 
at the meeting and those who submitted written comments [if 
final opinion was confirmed was given at a meeting] 
 
 “After ethical review – guidance for researchers” [SL-AR1 for 
CTIMPs, SL- AR2 for other studies]  
 
Copy to: Philip Diamond 
R&D office for NHS care organisation at lead site 
  
 
 
131
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The National Hospital for Neurology and Neurosurgery & Institute of 
Neurology Joint REC 
 
Attendance at Sub-Committee of the REC meeting on 24 March 2010 
 
 Committee Members:  
 
Name   Profession   Present   Notes    
Dr Yogi Amin  Consultant in 
Neuroanaesthesia & 
Neurocritical Care  
Yes    
Dr  Lorraine Ludman  Chartered 
Psychologist  
Yes    
 
 
 
 Version 1.0 14/12/2009; protocol version 2.0 14/12/2009 
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The National Hospital for Neurology and Neurosurgery
Queen Square
 London WC1N 3BG 
 Telephone: 020 7837 3611
 
LETTER TO POTENTIAL PARTICIPANTS 
PRIVATE AND CONFIDENTIAL 
Name 
Address 
 
Date 
 
Dear 
 
Following our recent telephone conversation I am writing to send you further 
information about the research study “Emotion recognition in Huntington’s disease”.  
I am enclosing an information sheet which contains details about why we are doing 
the study, and what is involved.  Please take your time to read it and think about 
whether or not you would be interested in taking part.  You might find it useful to 
discuss it with other people or to telephone me if you have any questions. 
As I said on the phone, I will wait for a few weeks for you to ring me and let me know 
whether you would like to take part in the study.  If I do not hear from you for more 
than a month I will ring you to check whether or not you are still interested. 
If you decide to take part, then when we next speak on the telephone I will arrange a 
time to meet up with you.  When we meet I will check whether you have any more 
questions and ask you to sign a consent form before you do the tasks.  We can 
either do them at your home, or you can come into London and do them at UCL (in 
Queen Square near the National Hospital), whichever you prefer. 
If you decide not to take part that is fine, and once I am aware of that I will not 
contact you any more about the study. 
 
Yours sincerely, 
 
 
 
Dr Susie Henley 
Trainee Clinical Psychologist 
e-mail: susie.henley@ucl.ac.uk 
phone:  
UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett Anderson 
& Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The Middlesex Hospital, 
National Hospital for Neurology & Neurosurgery, The Royal London Homoeopathic Hospital 
and University College Hospital.  
 Version 3.0 25/02/2010; protocol version 2.0 14/12/2009 
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UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett Anderson 
& Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The Middlesex Hospital, 
National Hospital for Neurology & Neurosurgery, The Royal London Homoeopathic Hospital 
and University College Hospital. 
CONTROL CONSENT FORM 
Name of study: Emotion recognition in Huntington’s disease 
Name of researcher: Dr Susie Henley  
Please initial each box 
Study information 
I confirm that I have read and understood the information sheet dated 
25/02/2010 v 4.0 for the above study.  I have had time to consider the 
information, ask questions, and have had these answered satisfactorily. 
Medical records 
I give my permission for members of the research team to view my 
medical records. 
MRI scan 
If I have previously had an MRI scan for research purposes at 
UCL/UCLH, I give permission for this scan to be used in the current study. 
Data protection and Data Sharing 
I understand that relevant sections of my medical notes and data 
collected during the study, may be looked at by individuals from 
regulatory authorities or from the NHS Trust, where it is relevant to my 
taking part in this research.  I give permission for these individuals to have 
access to my records. 
Voluntary participation 
I understand that my participation is entirely voluntary.  I am free to 
withdraw at any time, without giving a reason, and without my legal rights 
or medical care being affected. 
Contacting GP 
I consent to your contacting my GP to inform him / her of my participation 
in this study. 
 
Agreement 
I agree to take part in this study. 
 
 Version 3.0 25/02/2010; protocol version 2.0 14/12/2009 
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UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett Anderson 
& Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The Middlesex Hospital, 
National Hospital for Neurology & Neurosurgery, The Royal London Homoeopathic Hospital 
and University College Hospital. 
 
__________________ ____________ ___________________ 
Name of participant Date Signature 
 
__________________ ____________ ___________________ 
Name of person taking consent Date Signature 
 
When completed, 1 for participant; 1 for researcher site file; 1 (original) to be kept in 
medical notes. 
 Version 3.0 25/02/2010; protocol version 2.0 14/12/2009   
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UCL Hospitals is an NHS Trust incorporating the Eastman Dental Hospital, Elizabeth Garrett Anderson 
& Obstetric Hospital, The Heart Hospital, Hospital for Tropical Diseases, The Middlesex Hospital, 
National Hospital for Neurology & Neurosurgery, The Royal London Homoeopathic Hospital 
and University College Hospital. 
PATIENT CONSENT FORM 
Name of study: Emotion recognition in Huntington’s disease 
Name of researcher: Dr Susie Henley  
Please initial each box 
Study information 
I confirm that I have read and understood the information sheet dated 
25/02/2010 v 4.0 for the above study.  I have had time to consider the 
information, ask questions, and have had these answered satisfactorily. 
Medical records 
I give my permission for members of the research team to view my 
medical records. 
MRI scan 
If I have previously had an MRI scan for research purposes at 
UCL/UCLH, I give permission for this scan to be used in the current study. 
Data protection and Data Sharing 
I understand that relevant sections of my medical notes and data 
collected during the study, may be looked at by individuals from 
regulatory authorities or from the NHS Trust, where it is relevant to my 
taking part in this research.  I give permission for these individuals to have 
access to my records. 
Voluntary participation 
I understand that my participation is entirely voluntary.  I am free to 
withdraw at any time, without giving a reason, and without my legal rights 
or medical care being affected. 
Contacting GP 
I consent to your contacting my GP to inform him / her of my participation 
in this study. 
Agreement 
I agree to take part in this study. 
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__________________ ____________ ___________________ 
Name of participant Date Signature 
 
__________________ ____________ ___________________ 
Name of person taking consent Date Signature 
 
When completed, 1 for participant; 1 for researcher site file; 1 (original) to be kept in 
medical notes. 
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he National Hospital for NeuroloT gy and 
Neurosurgery
Queen Square
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CONTROL INFORMATION SHEET 
Name of study: Emotion recognition in Huntington’s disease 
We would like to invite you to take part in a research study. Before you decide you 
need to understand why the research is being done and what it would involve for 
you. Please take time to read the following information carefully. Talk to others 
about the study if you wish. 
Part 1 tells you the purpose of this study and what will happen to you if you take 
part. 
Part 2 gives you more detailed information about the conduct of the study. 
Ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
 
PART 1 
What is the purpose of the study? 
We already know that Huntington’s disease (HD) can affect how people recognise 
emotions.  For example, people with HD sometimes have difficulty recognising faces 
that look angry, or disgusted, or frightened.  The main question of this study is 
whether the difficulties people with HD have with emotion recognition mainly affects 
faces, or whether they show similar difficulties recognising other kinds of emotion, in 
voices and music (in other words, a more general problem understanding emotion 
rather than just a problem with facial expressions).  We hope that this will help us 
understand a little more about what it is like to have HD, and which areas of the 
brain are affected. 
Why have I been invited to take part? 
You have been invited because you are a partner, spouse or carer of someone with 
HD, or you were at risk of inheriting HD but have had a negative test for the gene 
mutation.  We are hoping that a total of 25 people with HD will take part in the study, 
as well as 25 people without HD. 
Do I have to take part? 
You do not have to take part in the study.  It is up to you to decide, and it is 
voluntary, which means that you can change your mind at any point, even after the 
study has started.  If you choose not to take part that is fine and will not affect any 
future medical care in any way.  If you would like to take part we will ask you to sign 
a consent form, but you can still decide to leave the study whenever you want. 
In order to take part in the study you must not meet any of the following criteria: 
• Aged under 18 or over 65 
• Past head injury 
• Past or current excessive use of alcohol 
• Past or current drug use 
• Current medical, neurological or mental health issue 
• English is not your first language 
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If you meet any of these criteria you do not need to disclose details to the 
researcher, but please let the researcher know that you do not wish to take part in 
the study. 
 
What will happen to me if I take part? 
If you would like to take part you will be asked to spend about two or three hours 
doing some tasks with a research psychologist.  This includes a questionnaire about 
your musical abilities but it does not matter whether you are musical or not (it is not 
a test of musical ability).  It also includes some pencil and paper tasks.  You will also 
be asked to look and listen to some pictures and sounds presented on a computer, 
but you do not need to be able to use a computer in order to answer the questions. 
There will be time to take breaks and have refreshments if you need them. 
You only need to do the tasks once, and this can be in your own home, or at the 
National Hospital in London, depending on what you would prefer.  We can refund 
second-class travel expenses for you if you opt to travel to the hospital to do the 
tasks. 
If you have had a brain scan (a magnetic resonance imaging or MRI scan) as part of 
another study, for example Track-HD, or the London HD study, then we will ask your 
permission to use that scan for this study.  You do not have to have a brain scan 
for this study. 
Are there any risks or side-effects? 
There are no physical risks from doing the tasks.  As this is a research study you will 
not be told how you have done on the tasks. 
What are the possible benefits of taking part? 
As the study does not involve any treatments, taking part will not help you medically.  
We hope that the results will tell us more about what it is like to have HD which may 
help us give more advice to people with HD and their carers. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
Will my taking part be kept confidential? 
Yes. We will follow the principles of good research governance in line with the Data 
Protection Act, and all information about you will be handled in confidence. The 
details are included in Part 2. We will ask your permission to inform your GP of your 
participation in the study. 
 
PART 2 
What will happen if I decide I want to leave the study half-way through? 
If you decide you want to leave the study at any point that is fine.  We will delete any 
research records we have for you and any results we have for you will not be used 
in the study. 
How will my data be stored? 
All of the data we collect about you is confidential and stored within the terms of the 
Data Protection Act (1998). 
The results are given a code unique to you (we do not use your real name).  The 
results are kept securely at UCL and only the people running and supervising the 
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study have access to them.  People from regulatory authorities can also request to 
have access to the data in order to check that all the results are being stored 
properly.  These people will also keep your data confidential.  
Your data are only being used for this study. 
We need to keep the data for about five years after we publish the results, because 
sometimes after results have been published people have questions about the 
findings.  After this time the records are destroyed. 
What will happen to the results of the study? 
After the results are analysed we will write to you with a summary of the findings.  
We will also try to publish the results in academic journals, and we may present 
them at conferences.  As we are interested in group results, we will never present or 
discuss your individual results with anyone.  You will never be identified in any 
report. 
Who is organising and funding the study? 
The study is organised by Dr Susie Henley, working with two supervisors, Dr John 
King (University College London) and Dr Jason Warren (Institute of Neurology).  
Susie is undertaking the study as part of her doctoral course in Clinical Psychology. 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. 
This study has been reviewed and given favourable opinion by the National Hospital 
for Neurology and Neurosurgery Research Ethics Committee. 
Complaints 
If you have a concern about any aspect of this study, you should ask to speak first to 
Dr Henley who will do her best to answer your questions (07528 254982). If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from the hospital. 
Compensation arrangements 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone's negligence, then 
you may have grounds for a legal action but you may have to pay for it.  Regardless 
of this, if you wish to complain, or have any concerns of this study, the normal 
National Health Service complaints mechanisms should be available to you. 
Who can I contact for more information? 
You may contact Dr Susie Henley on  or susie.henley@ucl.ac.uk 
You will be given a copy of this information sheet to keep. 
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The National Hospital for Neurology and 
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PATIENT INFORMATION SHEET 
Name of study: Emotion recognition in Huntington’s disease 
We would like to invite you to take part in a research study. Before you decide you 
need to understand why the research is being done and what it would involve for 
you. Please take time to read the following information carefully. Talk to others 
about the study if you wish. 
Part 1 tells you the purpose of this study and what will happen to you if you take 
part. 
Part 2 gives you more detailed information about the conduct of the study. 
Ask us if there is anything that is not clear or if you would like more information. 
Take time to decide whether or not you wish to take part. 
 
PART 1 
What is the purpose of the study? 
We already know that Huntington’s disease (HD) can affect how people recognise 
emotions.  For example, people with HD sometimes have difficulty recognising faces 
that look angry, or disgusted, or frightened.  The main question of this study is 
whether the difficulties people with HD have with emotion recognition mainly affects 
faces, or whether they show similar difficulties recognising other kinds of emotion, in 
voices and music (in other words, a more general problem understanding emotion 
rather than just a problem with facial expressions).  We hope that this will help us 
understand a little more about what it is like to have HD, and which areas of the 
brain are affected. 
Why have I been invited to take part? 
You have been invited because you have HD, and you have told us that you are 
interested in taking part in research.  We are hoping that a total of 25 people with 
HD will take part in the study, as well as 25 people without HD. 
Do I have to take part? 
You do not have to take part in the study.  It is up to you to decide, and it is 
voluntary, which means that you can change your mind at any point, even after the 
study has started.  If you choose not to take part that is fine and will not affect any 
future medical care in any way.  If you would like to take part we will ask you to sign 
a consent form, but you can still decide to leave the study whenever you want. 
Taking part in a research study is quite separate from the care you receive in clinic 
and from your GP.  Whether or not you take part in this study your medical care will 
carry on as normal and not be affected in any way. 
In order to take part in the study you must not meet any of the following criteria: 
• Aged under 18 or over 65 
• Past head injury 
• Past or current excessive use of alcohol 
• Past or current drug use 
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• Current medical, neurological or mental health issue 
• English is not your first language 
 
If you meet any of these criteria you do not need to disclose details to the 
researcher, but please let the researcher know that you do not wish to take part in 
the study. 
What will happen to me if I take part? 
If you would like to take part you will be asked to spend about two or three hours 
doing some tasks with a research psychologist.  This includes a questionnaire about 
your musical abilities but it does not matter whether you are musical or not (it is not 
a test of musical ability).  It also includes some pencil and paper tasks.  You will also 
be asked to look and listen to some pictures and sounds presented on a computer, 
but you do not need to be able to use a computer in order to answer the questions. 
There will be time to take breaks and have refreshments if you need them. 
You only need to do the tasks once, and this can be in your own home, or at the 
National Hospital in London, depending on what you would prefer.  We can refund 
second-class travel expenses for you if you opt to travel to the hospital to do the 
tasks. 
If you have had a brain scan (a magnetic resonance imaging or MRI scan) as part of 
another study, for example Track-HD, or the London HD study, then we will ask your 
permission to use that scan for this study.  You do not have to have a brain scan 
for this study. 
Are there any risks or side-effects? 
There are no physical risks from doing the tasks.  As this is a research study you will 
not be told how you have done on the tasks. 
What are the possible benefits of taking part? 
As the study does not involve any treatments, taking part will not help you medically.  
We hope that the results will tell us more about what it is like to have HD which may 
help us give more advice to people with HD and their carers. 
What if there is a problem? 
Any complaint about the way you have been dealt with during the study or any 
possible harm you might suffer will be addressed. The detailed information on this is 
given in Part 2. 
Will my taking part be kept confidential? 
Yes. We will follow the principles of good research governance in line with the Data 
Protection Act, and all information about you will be handled in confidence. The 
details are included in Part 2. We will ask your permission to inform your GP of your 
participation in the study. 
 
PART 2 
What will happen if I decide I want to leave the study half-way through? 
If you decide you want to leave the study at any point that is fine.  We will delete any 
research records we have for you and any results we have for you will not be used 
in the study. 
How will my data be stored? 
All of the data we collect about you is confidential and stored within the terms of the 
Data Protection Act (1998). 
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The results are given a code unique to you (we do not use your real name).  The 
results are kept securely at UCL and only the people running and supervising the 
study have access to them.  People from regulatory authorities can also request to 
have access to the data in order to check that all the results are being stored 
properly.  These people will also keep your data confidential.  
Your data are only being used for this study. 
We need to keep the data for about five years after we publish the results, because 
sometimes after results have been published people have questions about the 
findings.  After this time the records are destroyed. 
What will happen to the results of the study? 
After the results are analysed we will write to you with a summary of the findings.  
We will also try to publish the results in academic journals, and we may present 
them at conferences.  As we are interested in group results, we will never present or 
discuss your individual results with anyone.  You will never be identified in any 
report. 
Who is organising and funding the study? 
The study is organised by Dr Susie Henley, working with two supervisors, Dr John 
King (University College London) and Dr Jason Warren (Institute of Neurology).  
Susie is undertaking the study as part of her doctoral course in Clinical Psychology. 
Who has reviewed the study? 
All research in the NHS is looked at by independent group of people, called a 
Research Ethics Committee, to protect your safety, rights, wellbeing and dignity. 
This study has been reviewed and given favourable opinion by the National Hospital 
for Neurology and Neurosurgery Research Ethics Committee. 
Complaints 
If you have a concern about any aspect of this study, you should ask to speak first to 
Dr Henley who will do her best to answer your questions (07528 254982). If you 
remain unhappy and wish to complain formally, you can do this through the NHS 
Complaints Procedure.  Details can be obtained from the hospital. 
Compensation arrangements 
If you are harmed by taking part in this research project, there are no special 
compensation arrangements.  If you are harmed due to someone's negligence, then 
you may have grounds for a legal action but you may have to pay for it.  Regardless 
of this, if you wish to complain, or have any concerns of this study, the normal 
National Health Service complaints mechanisms should be available to you. 
Who can I contact for more information? 
You may contact Dr Susie Henley on 07528 254982 or susie.henley@ucl.ac.uk 
You will be given a copy of this information sheet to keep. 
 
 
APPENDIX 4: HAILSTONE MUSIC QUESTIONNAIRE 
1. Have you ever played a musical instrument? YES   NO  
Instrument Length of time in 
training (years) 
Length of time 
playing (years) 
Standard reached 
(grade level or 
equiv.) 
    
    
    
 
2. Do you play an instrument or sing regularly? YES   NO  
Instrument Time playing per week 
(hours) 
Where played 
(home/group) 
   
   
   
 
3. Do you listen to music regularly?  YES   NO  
If Yes: (a) How many hours per week do you listen to music?  _____ 
 
(b) What kind of music do you mainly listen to (pop, easy listening, jazz, classical, 
etc) 
_______________________________________________________ 
_______________________________________________________ 
 
4. Tunefulness 
Do you sing in tune?  YES   NO  
Does it sound in tune to you? YES   NO  CAN’T TELL  
Do other people think you sound in tune?  YES   NO  
 
5. Any other details that might be relevant? 
___________________________________________________________________
___________________________________________________________________
___________________________________________________________________
_____________________________________________ 
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APPENDIX 5: MUSICAL BACKGROUND OF PARTICIPANTS 
The Hailstone questionnaire collected data on the number of years for which 
participants had played an instrument (including voice), and how many hours a week 
they currently listened to any genre of music.  As both these variables were skewed 
within both groups, medians rather than means are presented.  Median time playing 
was 1 year (range 0 – 20 years) in controls (n=24), and 2 years (range 0 – 30 years) 
in the HD group (n=21).  Median time listening was 7 hours per week (range 0 – 70) 
in controls, and 7 hours per week (range 0 – 65) in the HD group.  (Note as 
mentioned in Part 2, section 2.3.5, 1 control and 4 HD participants were not asked to 
complete this questionnaire as it was not available when they were assessed). 
As the data were skewed and violated assumptions of Normality, Mann-Whitney U 
tests were used to compare playing time and listening time between groups.  There 
was no evidence that years of playing differed statistically significantly between 
groups (z=-1.08, p=0.28) or that hours per week listening differed statistically 
significantly between groups (z=0.24, p=0.81). 
Thus overall there was no evidence that in these measures of musical background, 
the groups differed significantly.  However these variables could not be used as 
covariates in the main analysis, firstly because of missing data, and secondly because 
they are retrospective, variable and not necessarily equivalent between participants 
(e.g. 10 years’ playing may equate to much more in one participant than another).  
These limitations are discussed further in Parts 2 and 3. 
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APPENDIX 6: PILOT STUDY OF MUSIC EMOTION STIMULI 
Selection of stimuli was based on an initial pilot study in 16 healthy participants who 
did not participate in any subsequent experiments.  Pilot participants were presented 
with a larger set of 104 musical excerpts (chosen by the author from Western 
classical music examples) and asked to rate each excerpt for how strongly it 
represented each of the four target emotions using a Likert scale ranging from 0 (not 
at all) to 4 (very strongly).  Ratings for each excerpt for each emotion were averaged.  
An excerpt for which one and only one emotion achieved a mean rating ≥ 2 was 
considered to portray that emotion (other excerpts were considered insufficiently 
salient, or ambiguous).  Excerpts fulfilling this criterion were ordered based on 
rating, and the 10 highest-ranking excerpts for each emotion were used in the test 
battery.  Mean (range) ratings for each emotion were as follows: anger, 3.0 (2.8 – 
3.8); fear, 3.1 (2.5 – 3.8); happiness, 3.2 (2.6 – 3.9); sadness, 2.8 (2.1 – 3.5). 
Anger 
Beethoven: Egmont Overture 
Beethoven: Symphony No. 6: Storm 
Dvorak: New World Symphony: Allegro con fuoco 
Dvorak: New World Symphony: Scherzo 
Elgar: Enigma Variation No. 4 
Holst: The Planets: Mars 
Saint Saens: Organ Symphony: Scherzo 
Shostakovich: Symphony No. 5: Allegro 
Shostakovich: Symphony No. 5: Moderato 
Vivaldi: The Four Seasons: Summer 
 
Fear 
Bartok: Bluebeard’s Castle: Lake of Tears 
Bartok: Music for Strings, Percussion and Celesta 
Goldenthal: Alien 3 Theme 
Hermmann: Psycho Theme 
Holst: The Planets: Saturn 
Horner: Aliens Theme 
Mussorgsky: Night on a Bare Mountain 
Mussorgsky: Pictures at an Exhibition: Cum Mortuis 
Schnittke: Concerto Grosso No. 3: Pesante 
Williams: Jaws Theme 
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Happiness 
Brahms: Romanze in F 
Moross: Big Country Theme 
Mozart: Marriage of Figaro Overture 
Pachelbel: Canon in D 
Puccini: La Boheme Overture 
Rimsky-Korsakov: Capriccio Espagnol Alborada 
Rimsky-Korsakov: Capriccio Espagnol Fandango 
Smetana: Má Vlast - Vltava 
Vivaldi: The Four Seasons: Autumn 
Williams: Jurassic Park Theme 
 
Sadness 
Barber: Adagio for Strings 
Beethoven: Pathetique Sonata: Grave 
Brahms: Intermezzo in A major, Opus 118 
Brahms: Symphony No 3: Poco Allegretto 
Puccini: La Boheme Finale 
Rimsky-Korsakov: Easter Festival Overture 
Rimsky-Korsakov: Scheherezade 
Shostakovich: Symphony No. 5: Allegro non troppo, clip 3 
Vaughan Williams: Fantasia on a Theme by Thomas Tallis 
Williams: Schindler’s List Theme 
 
 
 
 
 
APPENDIX 7: UNADJUSTED BEHAVIOURAL RESULTS FROM PART 2 
Mean (SD) neuropsychological performance, with differences (95% confidence intervals) with and without adjustment for age and 
estimated premorbid IQ (see Part 2, section 3.2) 
 Control HD Difference (HD – Control) 
 (N=25) (N=25) Crude Adjusted 
Benton Facial Recognition Test (/54) 48.4 (3.0) 45.5 (4.8) -3.0 (-5.3, -0.7) p=0.013  
Trail-Making Test A, sec 23.3 (6.4) 38.6 (15.5) 15.3 (10.3, 23,2) p<0.05 14.2 (9.3, 21.4) p<0.05 
Trail-Making Test B, sec 64.6 (29.0) 144.4 (80.4) 79.8 (49.1, 114.3) p<0.05 70.9 (43.9, 108.8) p<0.05 
Trail-Making Test B – A, sec 41.2 (25.6) 105.7 (71.5) 64.5 (36.0, 94.1) p<0.05 56.7 (29.5, 87.4) p<0.05 
Peretz Total Score (/120) 104.1 (8.7) 89.5 (11.0) -14.6 (-23.4, -5.7) p=0.003 -12.8 (-22.2, -3.4) p=0.011 
Note that the Benton score is already adjusted for age and education 
Adjusted differences are assumed to be constant at all levels of the covariates adjusted for 
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Odds of a correct response (95% confidence intervals) relative to controls for 
each emotion in each modality, unadjusted (see Part 2, Table 3-2 for 
comparison) 
 Intended emotion 
Faces Happy Sad Angry Fearful 
Controls  1 1 1 
Early HD  0.16 (0.05, 0.48)
p=0.001 
0.27 (0.17, 0.43) 
p<0.001 
0.07 (0.02, 0.20)
P<0.001 
 
 Intended emotion 
Voices Happy Sad Angry Fearful 
Controls 1 1 1 1 
Early HD 0.53 (0.30, 0.95) 
p=0.034 
0.38 (0.19, 0.76)
p=0.006 
0.34 (0.19, 0.62) 
p<0.001 
0.17 (0.09, 0.34)
p<0.001 
 
 Intended emotion 
Music Happy Sad Angry Fearful 
Controls 1 1 1 1 
Early HD 0.38 (0.17, 1.87) 
p=0.021 
0.35 (0.17, 0.73)
p=0.005 
0.37 (0.22, 0.64) 
p<0.001 
0.45 (0.27, 0.75)
p=0.002 
An odds ratio <1 means that the early HD group is less likely to recognise stimuli correctly than 
controls; where 95% confidence intervals are both <1 this means that the odds ratio is statistically 
significant at the p<0.05 level. 
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APPENDIX 8: DETAILS OF REGRESSION MODELS USED IN PART 2 
BACKGROUND DATA 
TMT A, TMT B, TMT B-A and Peretz scores were all (separately) modelled as a 
function of group (Control or HD), controlling for the effects of age and IQ by 
including them as covariates (equation 1) 
 Score = β1 group + β2 age + β3 IQ + μ + ε (1) 
where μ is a constant and ε is an error term. 
Because of the non-normality of the data 95% accelerated bias-corrected bootstrap 
confidence intervals were estimated for the parameters for all three Trail-Making 
scores.  Detailed results for each variable are shown in the following tables. 
Regression coefficients for TMT A 
TMT A Observed coefficient 
(β) 
95% accelerated bias-corrected 
bootstrap CI 
Group 14.18 9.32, 21.44 (p<0.05) 
Age 0.21 -0.01, 0.43 (p>0.05) 
IQ -0.06 -0.45, 0.17 (p>0.05) 
Constant 19.50 -8.48, 64.77 (p>0.05) 
Adjusted R2 = 0.29 
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Regression coefficients for TMT B 
TMT B Observed coefficient 
(β) 
95% accelerated bias-corrected 
bootstrap CI 
Group 70.87 43.90, 108.82 (p<0.05) 
Age 1.53 0.29, 2.73 (p<0.05) 
IQ -1.00 -2.47, 0.13 (p>0.05) 
Constant 99.17 -32.76, 272.38 (p>0.05) 
Adjusted R2 = 0.36 
Regression coefficients for TMT B-A 
TMT B-A Observed coefficient 
(β) 
95% accelerated bias-corrected 
bootstrap CI 
Group 56.69 29.50, 87.40 (p<0.05) 
Age 1.32 0.15, 2.56 (p<0.05) 
IQ -0.94 -2.16, 0.04 (p>0.05) 
Constant 79.67 -27.44, 205.03 (p>0.05) 
Adjusted R2 = 0.32 
Regression coefficients for Peretz score 
Peretz Observed 
coefficient (β) 
t(18) 95% CI 
Group -12.78 -2.85 (p=0.011) -22.20, -3.37 
Age -0.11 -0.69 (p=0.50) -0.43, 0.22 
IQ 0.30 1.67 (p=0.11) -0.08, 0.68 
Constant 75.08 3.42 (p=0.003) 28.89, 121.27 
Adjusted R2 = 0.38 
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Age contributed significantly to TMT B and TMT B-A scores, and was only just 
non-significant for TMT A.  IQ tended to have small, non-significant effects on 
outcome, although also was approaching statistical significance for TMT B-A.  
Nevertheless it was though important to keep both these predictors in all the models.  
Lack of evidence that a potential predictor affects outcome significantly can be due 
to lack of power, and even a predictor that does not reach statistical significance can 
materially affect the outcome variable in conjunction with other predictors.  Johnson 
et al. (2007) make the point that variables such as age and IQ often have subtle 
effects on outcomes, but that most small studies are underpowered to detect them; 
they recommend that studies still include them as covariates because of this 
evidence.  This also means that the effects reported here are comparable with those 
from other studies that also adjust for age and IQ. 
EMOTION RECOGNITION DATA 
Probability of a correct emotion recognition response was modelled as a function of 
group, modality, emotion and their interactions, controlling for the effects of age, IQ, 
Benton facial recognition ability, Trail-Making B-A score and gender by including 
them as covariates.  Adjusted odds ratios for each emotion and modality are 
presented in the main body of the thesis.  Conditional odds ratios for age, IQ, Benton, 
TMT B-A and gender are presented below. 
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Conditional odds ratios from the emotion recognition model 
Emotion recognition Odds ratio 95% CI 
Age 0.98 (p=0.01) 0.96, 0.99 
IQ 1.02 (p=0.016) 1.00, 1.03 
Benton 1.03 (p=0.14) 0.99, 1.07 
TMT B-A 1.00 (p=0.58) 0.996, 1.002 
Gender 1.09 (p=0.57) 0.81, 1.47 
 
In this model age and IQ had statistically significant effects on outcome.  Benton, 
TMT B-A and gender did not.  However theoretically it is known that gender and 
facial recognition ability have effects on facial emotion recognition (Henley et al., 
2008; Johnson et al., 2007), and that executive function is likely to have an impact as 
well (Omar et al., 2011) and therefore, as above, it was thought appropriate to 
include these covariates. 
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APPENDIX 9: BATTERY ORDER 
1. Trail-Making Test A & B 
2. Benton Facial Recognition Test 
3. Peretz Battery of Amusia 
4. Multimodal Emotion Recognition 
5. Hailstone Music Questionnaire 
6. NART 
 
 
